{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "161bf749",
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "import os\n",
    "script_dir = os.getcwd()\n",
    "root_dir = os.path.join(os.path.dirname(os.path.abspath(script_dir)))\n",
    "sys.path.append(os.path.join(os.path.dirname(os.path.abspath(script_dir))))\n",
    "os.chdir(root_dir)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 197,
   "id": "54d06a22",
   "metadata": {},
   "outputs": [],
   "source": [
    "from utils.io import save_object, load_object\n",
    "import pandas as pd\n",
    "from sklearn.model_selection import train_test_split\n",
    "import json\n",
    "_VERSION=\"v1\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "3fcffb2d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "prompt",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cancer_category",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cancer_type",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "biomarker",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "6b123e22-7fb9-4da4-8fe0-70901c899612",
       "rows": [
        [
         "0",
         "what is the first-line treatment of metastatic urothelial carcinoma with fgfr3 s249c mutation?",
         "GU",
         "['urothelial carcinoma', 'metastatic']",
         "['fgfr3']"
        ],
        [
         "1",
         "are parp inhibitors used for patients with leiomyosarcoma who have mutations in dna damage repair genes?",
         "Sarcoma",
         "['leiomyosarcoma']",
         "['dna', 'parp']"
        ],
        [
         "2",
         "are alk inhibitors approved for use in tfcp2 fusion positive rhabdomyosarcoma?",
         "Sarcoma",
         "['rhabdomyosarcoma']",
         "['alk', 'tfcp2']"
        ],
        [
         "3",
         "for a patient with cancer metastatic prostate cancer, advanced stage (most often stage iv, but some stage iii or earlier potentially) and with brca2 mutation, what drugs approved?",
         "GU",
         "['prostate cancer', 'cancer']",
         "['brca2']"
        ],
        [
         "4",
         "for a patient with her2+ breast cancer after neoadjvuant chemotherapy + trastuzumab then surgery, if residual disease at time of surgery, what treatment options are approved afterwards?",
         "Breast",
         "['breast cancer', 'disease']",
         "['her2']"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>prompt</th>\n",
       "      <th>cancer_category</th>\n",
       "      <th>cancer_type</th>\n",
       "      <th>biomarker</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>what is the first-line treatment of metastatic...</td>\n",
       "      <td>GU</td>\n",
       "      <td>['urothelial carcinoma', 'metastatic']</td>\n",
       "      <td>['fgfr3']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>are parp inhibitors used for patients with lei...</td>\n",
       "      <td>Sarcoma</td>\n",
       "      <td>['leiomyosarcoma']</td>\n",
       "      <td>['dna', 'parp']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>are alk inhibitors approved for use in tfcp2 f...</td>\n",
       "      <td>Sarcoma</td>\n",
       "      <td>['rhabdomyosarcoma']</td>\n",
       "      <td>['alk', 'tfcp2']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>for a patient with cancer metastatic prostate ...</td>\n",
       "      <td>GU</td>\n",
       "      <td>['prostate cancer', 'cancer']</td>\n",
       "      <td>['brca2']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>for a patient with her2+ breast cancer after n...</td>\n",
       "      <td>Breast</td>\n",
       "      <td>['breast cancer', 'disease']</td>\n",
       "      <td>['her2']</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              prompt cancer_category  \\\n",
       "0  what is the first-line treatment of metastatic...              GU   \n",
       "1  are parp inhibitors used for patients with lei...         Sarcoma   \n",
       "2  are alk inhibitors approved for use in tfcp2 f...         Sarcoma   \n",
       "3  for a patient with cancer metastatic prostate ...              GU   \n",
       "4  for a patient with her2+ breast cancer after n...          Breast   \n",
       "\n",
       "                              cancer_type         biomarker  \n",
       "0  ['urothelial carcinoma', 'metastatic']         ['fgfr3']  \n",
       "1                      ['leiomyosarcoma']   ['dna', 'parp']  \n",
       "2                    ['rhabdomyosarcoma']  ['alk', 'tfcp2']  \n",
       "3           ['prostate cancer', 'cancer']         ['brca2']  \n",
       "4            ['breast cancer', 'disease']          ['her2']  "
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "real_world_db_entity_mapped=pd.read_csv(f\"data/real_world_db/real_world_db_entity_mapped_cancerAnnot__{_VERSION}.csv\", index_col=0)\n",
    "real_world_db_entity_mapped.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "03a6ebe7",
   "metadata": {},
   "outputs": [],
   "source": [
    "val, test = train_test_split(\n",
    "    real_world_db_entity_mapped,\n",
    "    test_size=0.75,\n",
    "    stratify=real_world_db_entity_mapped['cancer_category'],\n",
    "    random_state=42\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 175,
   "id": "68648c49",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "dataset",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "count",
         "rawType": "int64",
         "type": "integer"
        }
       ],
       "ref": "ce5f00d5-a025-4ab1-9986-bb3d77e53d53",
       "rows": [
        [
         "test",
         "77"
        ],
        [
         "validation",
         "25"
        ]
       ],
       "shape": {
        "columns": 1,
        "rows": 2
       }
      },
      "text/plain": [
       "dataset\n",
       "test          77\n",
       "validation    25\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 175,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "real_world_db_entity_mapped['dataset'] = None\n",
    "real_world_db_entity_mapped.loc[val.index, 'dataset'] = 'validation'\n",
    "real_world_db_entity_mapped.loc[test.index, 'dataset'] = 'test'\n",
    "real_world_db_entity_mapped.dataset.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "3b887254",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Validation\n",
      "cancer_category\n",
      "GU             0.20\n",
      "GI             0.20\n",
      "Hematologic    0.12\n",
      "Breast         0.08\n",
      "CNS            0.08\n",
      "Sarcoma        0.08\n",
      "Lung           0.08\n",
      "Other          0.04\n",
      "Skin           0.04\n",
      "Endocrine      0.04\n",
      "Unspecified    0.04\n",
      "Name: proportion, dtype: float64\n",
      "\n",
      "Test\n",
      "cancer_category\n",
      "GU             0.220779\n",
      "GI             0.207792\n",
      "Hematologic    0.116883\n",
      "Breast         0.103896\n",
      "CNS            0.090909\n",
      "Lung           0.064935\n",
      "Sarcoma        0.064935\n",
      "Endocrine      0.051948\n",
      "GYN            0.025974\n",
      "Unspecified    0.025974\n",
      "Other          0.012987\n",
      "Skin           0.012987\n",
      "Name: proportion, dtype: float64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for split_name, split_df in zip(['Validation','Test'], [val,test]):\n",
    "    print(split_name)\n",
    "    print(split_df['cancer_category'].value_counts(normalize=True))\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "19e1bcea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAgkAAAGsCAYAAABXWzQ4AAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMywgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/OQEPoAAAACXBIWXMAAA9hAAAPYQGoP6dpAABs/0lEQVR4nO3dd1hT1/8H8HdACBtkyFCUqaDFhVURtyhat9TdAoqr4MSJC7Aq1VbEibZVwNZtrbW2TureqKhVREXcIlYFBGRI7u8Pf+RrJCpgIEjer+fJ85hzzz33c5NIPjn3nHNFgiAIICIiInqLmrIDICIiooqJSQIRERHJxSSBiIiI5GKSQERERHIxSSAiIiK5mCQQERGRXEwSiIiISC4mCURERCQXkwQiIiKSi0kCfTJCQkIgEolkymxsbODr61vmx759+zZEIhGio6OlZb6+vtDT0yvzYxcSiUQICQkpt+PRx/H19YWNjY1MGd9D+tSoZJKQlJSEkSNHws7ODlpaWjAwMIC7uzuWLFmCly9fKju8MrNy5UqZLzlV9ffff1fYP9QVOTZSvBMnTiAkJARpaWnKDoVIrirKDqC8/fXXX+jbty/EYjG8vb3x2WefIS8vD8eOHcPkyZNx5coV/Pjjj8oOs0ysXLkSpqam5fLLu7wkJiZCTa1kue7ff/+NFStWlOjLuFatWnj58iU0NDRKGGHJvC+2ly9fokoVlfsvW6m8/R6eOHECoaGh8PX1hZGRkfICI3oHlfqLk5ycjAEDBqBWrVr4559/YGlpKd0WEBCAmzdv4q+//lJihB9HIpEgLy8PWlpayg6l3IjF4jJt/9WrV5BIJNDU1FT666rs45eVrKws6OrqKjuMclFZ30OqvFTqcsPChQuRmZmJNWvWyCQIhRwcHDBu3Djp86ioKLRv3x7VqlWDWCxG3bp1ERkZWWQ/GxsbdOvWDceOHUPTpk2hpaUFOzs7rFu3rkjdtLQ0TJgwATY2NhCLxahRowa8vb3x33//Sevk5uYiODgYDg4OEIvFsLa2xpQpU5CbmyvTlkgkwujRo7F+/XrUq1cPYrEYe/bskXvuNjY2uHLlCg4fPgyRSASRSIS2bdvi1q1bEIlEWLx4cZF9Tpw4AZFIhI0bNwL435iAa9euoV+/fjAwMICJiQnGjRuHnJycIvv/+uuvcHV1hba2NoyNjTFgwADcu3dPbnxvO3bsGD7//HNoaWnB3t4eq1evfud5vdkzkp+fj9DQUDg6OkJLSwsmJiZo2bIl9u/fD+D1deIVK1ZIX7/CB/C/cQc//PADIiIiYG9vD7FYjKtXr8odk1Do1q1b8PT0hK6uLqysrDBnzhy8eXPVQ4cOQSQS4dChQzL7vd3m+2IrLHu7h+HChQvo0qULDAwMoKenhw4dOuDUqVMydaKjoyESiXD8+HEEBgbCzMwMurq66N27N548eSL/DXjDpUuX4OvrK708Z2FhgaFDh+Lp06dF6j548AB+fn6wsrKCWCyGra0tvvnmG+Tl5cnEcvjwYfj7+6NatWqoUaOGdP+VK1dKP8tWVlYICAgo0hV/48YNeHl5wcLCAlpaWqhRowYGDBiA9PR0aZ39+/ejZcuWMDIygp6eHurUqYPp06d/8Fw/tF/he7l582ZMnz4dFhYW0NXVRY8ePYr12X7zPQwJCcHkyZMBALa2ttL3+/bt2x91DkSKpFI9CX/++Sfs7OzQokWLYtWPjIxEvXr10KNHD1SpUgV//vkn/P39IZFIEBAQIFP35s2b+PLLL+Hn5wcfHx+sXbsWvr6+cHV1Rb169QAAmZmZaNWqFRISEjB06FA0btwY//33H3bu3In79+/D1NQUEokEPXr0wLFjxzBixAg4Ozvj8uXLWLx4Ma5fv44dO3bIHPeff/7Bli1bMHr0aJiamhYZKFUoIiICY8aMgZ6eHmbMmAEAMDc3h52dHdzd3bF+/XpMmDBBZp/169dDX18fPXv2lCnv168fbGxsEBYWhlOnTmHp0qV4/vy5TFI0b948zJo1C/369cOwYcPw5MkTLFu2DK1bt8aFCxfe27V6+fJldOrUCWZmZggJCcGrV68QHBwMc3Pz971dAF7/4Q0LC8OwYcPQtGlTZGRkIC4uDufPn0fHjh0xcuRIPHz4EPv378cvv/wit42oqCjk5ORgxIgREIvFMDY2hkQikVu3oKAAnTt3RvPmzbFw4ULs2bMHwcHBePXqFebMmfPBeN9UnNjedOXKFbRq1QoGBgaYMmUKNDQ0sHr1arRt2xaHDx9Gs2bNZOqPGTMGVatWRXBwMG7fvo2IiAiMHj0amzdvfu9x9u/fj1u3bmHIkCGwsLCQXpK7cuUKTp06JU1kHj58iKZNmyItLQ0jRoyAk5MTHjx4gG3btiE7OxuamprSNv39/WFmZobZs2cjKysLwOv3LjQ0FB4eHvjmm2+QmJiIyMhInD17FsePH4eGhgby8vLg6emJ3NxcjBkzBhYWFnjw4AF27dqFtLQ0GBoa4sqVK+jWrRvq16+POXPmQCwW4+bNmzh+/PgHX8/i7jdv3jyIRCJMnToVqampiIiIgIeHB+Lj46Gtrf3B9w4A+vTpg+vXr2Pjxo1YvHgxTE1NAQBmZmalPgcihRNURHp6ugBA6NmzZ7H3yc7OLlLm6ekp2NnZyZTVqlVLACAcOXJEWpaamiqIxWJh4sSJ0rLZs2cLAITt27cXaVcikQiCIAi//PKLoKamJhw9elRm+6pVqwQAwvHjx6VlAAQ1NTXhypUrxTqfevXqCW3atClSvnr1agGAkJCQIC3Ly8sTTE1NBR8fH2lZcHCwAEDo0aOHzP7+/v4CAOHixYuCIAjC7du3BXV1dWHevHky9S5fvixUqVKlSPnbevXqJWhpaQl37tyRll29elVQV1cX3v7I1qpVSybGBg0aCF27dn1v+wEBAUXaEQRBSE5OFgAIBgYGQmpqqtxtUVFR0jIfHx8BgDBmzBhpmUQiEbp27SpoamoKT548EQRBEA4ePCgAEA4ePPjBNt8VmyC8fr+Dg4Olz3v16iVoamoKSUlJ0rKHDx8K+vr6QuvWraVlUVFRAgDBw8ND+jkTBEGYMGGCoK6uLqSlpck9XiF5/w82btxY5DPv7e0tqKmpCWfPni1Sv/C4hbG0bNlSePXqlXR7amqqoKmpKXTq1EkoKCiQli9fvlwAIKxdu1YQBEG4cOGCAEDYunXrO+NdvHixAED6+hdXcfYrfC+rV68uZGRkSMu3bNkiABCWLFkiLfPx8RFq1aols//b7+H3338vABCSk5MVcg5EiqYylxsyMjIAAPr6+sXe581fBOnp6fjvv//Qpk0b3Lp1S6ZrEwDq1q2LVq1aSZ+bmZmhTp06uHXrlrTst99+Q4MGDdC7d+8ixyr8NbZ161Y4OzvDyckJ//33n/TRvn17AMDBgwdl9mvTpg3q1q1b7HOSp1+/ftDS0sL69eulZXv37sV///2Hr776qkj9t3tRxowZA+D1oDsA2L59OyQSCfr16ydzDhYWFnB0dCxyDm8qKCjA3r170atXL9SsWVNa7uzsDE9Pzw+ei5GREa5cuYIbN258sO67eHl5wczMrNj1R48eLf134SWgvLw8HDhwoNQxfEhBQQH27duHXr16wc7OTlpuaWmJQYMG4dixY9LPfKERI0bIXL5o1aoVCgoKcOfOnfce683/Bzk5Ofjvv//QvHlzAMD58+cBvB4Ps2PHDnTv3h1NmjQp0sbbU1eHDx8OdXV16fMDBw4gLy8P48ePlxmIOnz4cBgYGEjHChkaGgJ4/fnMzs6WG29hL9Uff/zxzh6gj93P29tb5m/Jl19+CUtLS+n/gY9V2nMgUjSVSRIMDAwAAC9evCj2PsePH4eHhwd0dXVhZGQEMzMz6TXBt5OEN7/QClWtWhXPnz+XPk9KSsJnn3323mPeuHEDV65cgZmZmcyjdu3aAIDU1FSZ+ra2tsU+n3cxMjJC9+7dsWHDBmnZ+vXrUb16dWly8iZHR0eZ5/b29lBTU5NeS71x4wYEQYCjo2OR80hISChyDm968uQJXr58WeQYAFCnTp0PnsucOXOQlpaG2rVrw8XFBZMnT8alS5c+uN+bSvKaqqmpyXxJA5C+V4WvR1l48uQJsrOz5b4mzs7OkEgkRa6Rv/0ZrVq1KgDIfEblefbsGcaNGwdzc3Noa2vDzMxM+hoV/j948uQJMjIyPvj5LvT2a1yYqLx9PpqamrCzs5Nut7W1RWBgIH7++WeYmprC09MTK1askPn/2L9/f7i7u2PYsGEwNzfHgAEDsGXLlg9+2ZZkv7c/nyKRCA4ODgp7z0t7DkSKpjJjEgwMDGBlZYV///23WPWTkpLQoUMHODk5ITw8HNbW1tDU1MTff/+NxYsXF/nP+uavojcJbwxgKw6JRAIXFxeEh4fL3W5tbS3zvLjXPz/E29sbW7duxYkTJ+Di4oKdO3fC39+/WNML3/6VKJFIIBKJsHv3brmvS1kuQNS6dWskJSXhjz/+wL59+/Dzzz9j8eLFWLVqFYYNG1asNhT1mhZ6+/UpVFBQoNDjfEhpP6P9+vXDiRMnMHnyZDRs2BB6enqQSCTo3Llzqb+0PuY1XrRoEXx9faXv8dixY6XjY2rUqAFtbW0cOXIEBw8exF9//YU9e/Zg8+bNaN++Pfbt2/fO16G0+5WFihQLqTaVSRIAoFu3bvjxxx9x8uRJuLm5vbfun3/+idzcXOzcuVPmF9j7uso/xN7e/oNJir29PS5evIgOHTq888ultN7XXufOnWFmZob169ejWbNmyM7Oxtdffy237o0bN2R+Cd68eRMSiUQ6aNLe3h6CIMDW1lb6q7q4zMzMoK2tLfdyQWJiYrHaMDY2xpAhQzBkyBBkZmaidevWCAkJkSYJinxdJRIJbt26JXOe169fBwDp61H4i/3tUfryuvmLG5uZmRl0dHTkvibXrl2DmppakYSyNJ4/f47Y2FiEhoZi9uzZ0vK33x8zMzMYGBgUOwl/W61atQC8fo/f7JnJy8tDcnIyPDw8ZOq7uLjAxcUFM2fOxIkTJ+Du7o5Vq1Zh7ty5AF738HTo0AEdOnRAeHg45s+fjxkzZuDgwYNF2npTcfd7+/wFQcDNmzdRv379Ep33+97v0p4DkSKpzOUGAJgyZQp0dXUxbNgwPH78uMj2pKQkLFmyBMD/fnW9+SsrPT0dUVFRpT6+l5cXLl68iN9//73ItsLj9OvXDw8ePMBPP/1UpM7Lly+lI8FLQ1dX950ru1WpUgUDBw7Eli1bEB0dDRcXl3f+wSucpldo2bJlAIAuXboAeD1qW11dHaGhoUV+pQqCIHfqXCF1dXV4enpix44duHv3rrQ8ISEBe/fu/eA5vt22np4eHBwcZKaPFs7JV9Qqd8uXL5f+WxAELF++HBoaGujQoQOA11+A6urqOHLkiMx+K1euLNJWcWNTV1dHp06d8Mcff8h0cT9+/BgbNmxAy5YtpZfYPoa8/wfA69kyb1JTU0OvXr3w559/Ii4urkg7H+qt8PDwgKamJpYuXSpTd82aNUhPT0fXrl0BvB5b9OrVK5l9XVxcoKamJn2Pnz17VqT9hg0bAkCRacRvKsl+69atk7l0uW3bNjx69Ej6f6C43vV+l/YciBRNpXoS7O3tsWHDBvTv3x/Ozs4yKy6eOHECW7dulc6579SpEzQ1NdG9e3eMHDkSmZmZ+Omnn1CtWjU8evSoVMefPHkytm3bhr59+2Lo0KFwdXXFs2fPsHPnTqxatQoNGjTA119/jS1btmDUqFE4ePAg3N3dUVBQgGvXrmHLli3Yu3ev3IFhxeHq6orIyEjMnTsXDg4OqFatmsyYA29vbyxduhQHDx7EggUL3tlOcnIyevTogc6dO+PkyZP49ddfMWjQIDRo0ADA69d57ty5CAoKwu3bt9GrVy/o6+sjOTkZv//+O0aMGIFJkya9s/3Q0FDs2bMHrVq1gr+/P169eoVly5ahXr16HxxfULduXbRt2xaurq4wNjZGXFwctm3bJjO40NXVFQAwduxYeHp6Ql1dHQMGDCjWa/g2LS0t7NmzBz4+PmjWrBl2796Nv/76C9OnT5cOfjQ0NETfvn2xbNkyiEQi2NvbY9euXXLHZpQktrlz50rn0vv7+6NKlSpYvXo1cnNzsXDhwlKdz9sMDAzQunVrLFy4EPn5+ahevTr27duH5OTkInXnz5+Pffv2oU2bNtLpu48ePcLWrVtx7Nix9057NTMzQ1BQEEJDQ9G5c2f06NEDiYmJWLlyJT7//HPpANp//vkHo0ePRt++fVG7dm28evUKv/zyC9TV1eHl5QXg9biUI0eOoGvXrqhVqxZSU1OxcuVK1KhRAy1btnxnDCXZz9jYGC1btsSQIUPw+PFjREREwMHBAcOHDy/R61v4fs+YMQMDBgyAhoYGunfvXupzIFI4pcypULLr168Lw4cPF2xsbARNTU1BX19fcHd3F5YtWybk5ORI6+3cuVOoX7++oKWlJdjY2AgLFiwQ1q5dW2TKUq1ateROu2vTpk2RKYdPnz4VRo8eLVSvXl3Q1NQUatSoIfj4+Aj//feftE5eXp6wYMECoV69eoJYLBaqVq0quLq6CqGhoUJ6erq0HgAhICCg2OedkpIidO3aVdDX1xcAyJ0OWa9ePUFNTU24f/9+kW2FUyCvXr0qfPnll4K+vr5QtWpVYfTo0cLLly+L1P/tt9+Eli1bCrq6uoKurq7g5OQkBAQECImJiR+M9fDhw4Krq6ugqakp2NnZCatWrZIe/01vT4GcO3eu0LRpU8HIyEjQ1tYWnJychHnz5gl5eXnSOq9evRLGjBkjmJmZCSKRSNpm4ZTE77//vkg875oCqaurKyQlJQmdOnUSdHR0BHNzcyE4OFhmGp8gCMKTJ08ELy8vQUdHR6hataowcuRI4d9//y3S5rtiE4Si0+cEQRDOnz8veHp6Cnp6eoKOjo7Qrl074cSJEzJ1Cqcdvj018V1TM992//59oXfv3oKRkZFgaGgo9O3bV3j48KHceO7cuSN4e3sLZmZmglgsFuzs7ISAgAAhNzf3vbEUWr58ueDk5CRoaGgI5ubmwjfffCM8f/5cuv3WrVvC0KFDBXt7e0FLS0swNjYW2rVrJxw4cEBaJzY2VujZs6dgZWUlaGpqClZWVsLAgQOF69evv/c8i7Nf4Wu2ceNGISgoSKhWrZqgra0tdO3aVWbKriAUbwqkIAjCt99+K1SvXl1QU1OT/m0p7TkQKZpIEEo4so4qtUaNGsHY2BixsbFFthUudvPkyRPpwi9EquTQoUNo164dtm7dii+//FLZ4RCVOZUak0DvFxcXh/j4eHh7eys7FCIiqgBUakwCyffvv//i3LlzWLRoESwtLdG/f39lh0RERBUAexII27Ztw5AhQ5Cfn4+NGzfyTnVERAQA4JgEIiIikos9CURERCRXpR+TIJFI8PDhQ+jr6yt8BUMiImUQBAEvXryAlZVVsZZOJyo1Zc6/fPXqlTBz5kzBxsZG0NLSEuzs7IQ5c+bI3M5WIpEIs2bNEiwsLAQtLS2hQ4cOJZorfO/ePQEAH3zwwUele9y7d68s/jQTSSm1J2HBggWIjIxETEwM6tWrh7i4OAwZMgSGhoYYO3YsAGDhwoVYunQpYmJiYGtri1mzZsHT0xNXr14t1gC7wtu53rt3TyHL1BIRKVtGRgasra1lbldNVBaUOnCxW7duMDc3x5o1a6RlXl5e0NbWxq+//gpBEGBlZYWJEydKl/FNT0+Hubk5oqOji7WUbkZGBgwNDZGens4kgYgqBf5do/Ki1ItZLVq0QGxsrPSueRcvXsSxY8ekN0lJTk5GSkqKzB3PDA0N0axZM5w8eVJum7m5ucjIyJB5EBERUckp9XLDtGnTkJGRAScnJ6irq6OgoADz5s3D4MGDAQApKSkAAHNzc5n9zM3NpdveFhYWhtDQ0LINnIiISAUotSdhy5YtWL9+PTZs2IDz588jJiYGP/zwA2JiYkrdZlBQENLT06WPe/fuKTBiIiIi1aHUnoTJkydj2rRp0rEFLi4uuHPnDsLCwuDj4wMLCwsAwOPHj2FpaSnd7/Hjx9J7q79NLBZDLBaXeexERESVnVJ7ErKzs4vM8VVXV4dEIgEA2NrawsLCQuaOhBkZGTh9+jTc3NzKNVYiIiJVo9SehO7du2PevHmoWbMm6tWrhwsXLiA8PBxDhw4FAIhEIowfPx5z586Fo6OjdAqklZUVevXqpczQiYiIKj2lJgnLli3DrFmz4O/vj9TUVFhZWWHkyJGYPXu2tM6UKVOQlZWFESNGIC0tDS1btsSePXt4EyIiIqIyVulv8MT5xERU2fDvGpUXLvpNREREcjFJICIiIrmYJBAREZFcTBKIiIhILqXObiCiT9vxNSuUHYJCufsFKDsEogqFPQlEREQkF5MEIiIikotJAhEREcnFJIGIiIjkYpJAREREcjFJICIiIrmYJBAREZFcXCeBiErt1L7dyg5BobhOApEs9iQQERGRXEwSiIiISC5ebiCiUnMbtFDZIdA7CIKAV69eoaCgQNmhUAWjrq6OKlWqQCQSfbAukwQiokomLy8Pjx49QnZ2trJDoQpKR0cHlpaW0NTUfG89JglERJWIRCJBcnIy1NXVYWVlBU1NzWL9YiTVIAgC8vLy8OTJEyQnJ8PR0RFqau8eecAkgYioEsnLy4NEIoG1tTV0dHSUHQ5VQNra2tDQ0MCdO3eQl5cHLS2td9blwEUiokrofb8OiYr7+eCniIiIiORikkBERERycUwCEZEKsJn2V7ke7/Z3Xcv1eFQ22JNAREQVgq+vL0QikfRhYmKCzp0749KlS0qNKzo6GkZGRkqNQVmYJBARUYXRuXNnPHr0CI8ePUJsbCyqVKmCbt26vbN+fn5+OUanepgkEBFRhSEWi2FhYQELCws0bNgQ06ZNw7179/DkyRPcvn0bIpEImzdvRps2baClpYX169cDAH7++Wc4OztDS0sLTk5OWLlypUy7U6dORe3ataGjowM7OzvMmjVLJsG4ePEi2rVrB319fRgYGMDV1RVxcXE4dOgQhgwZgvT0dGkPR0hISHm+JErFMQlERFQhZWZm4tdff4WDgwNMTEyQlZUFAJg2bRoWLVqERo0aSROF2bNnY/ny5WjUqBEuXLiA4cOHQ1dXFz4+PgAAfX19REdHw8rKCpcvX8bw4cOhr6+PKVOmAAAGDx6MRo0aITIyEurq6oiPj4eGhgZatGiBiIgIzJ49G4mJiQAAPT095bwgSqDUJMHGxgZ37twpUu7v748VK1YgJycHEydOxKZNm5CbmwtPT0+sXLkS5ubmSoiWiIjK2q5du6RfwllZWbC0tMSuXbtk5vWPHz8effr0kT4PDg7GokWLpGW2tra4evUqVq9eLU0SZs6cKa1vY2ODSZMmYdOmTdIk4e7du5g8eTKcnJwAAI6OjtL6hoaGEIlEsLCwKKOzrriUernh7Nmz0mtPjx49wv79+wEAffv2BQBMmDABf/75J7Zu3YrDhw/j4cOHMh8MIiKqXNq1a4f4+HjEx8fjzJkz8PT0RJcuXWR+UDZp0kT676ysLCQlJcHPzw96enrSx9y5c5GUlCStt3nzZri7u8PCwgJ6enqYOXMm7t69K90eGBiIYcOGwcPDA999953MvqpMqUmCmZmZ9NqThYUFdu3aBXt7e7Rp0wbp6elYs2YNwsPD0b59e7i6uiIqKgonTpzAqVOnlBk2ERGVEV1dXTg4OMDBwQGff/45fv75Z2RlZeGnn36SqVMoMzMTAPDTTz9Jk4v4+Hj8+++/0u+KkydPYvDgwfjiiy+wa9cuXLhwATNmzEBeXp60nZCQEFy5cgVdu3bFP//8g7p16+L3338vp7OuuCrMmIS8vDz8+uuvCAwMhEgkwrlz55Cfnw8PDw9pHScnJ9SsWRMnT55E8+bN5baTm5uL3Nxc6fOMjIwyj52IiMqGSCSCmpoaXr58KXe7ubk5rKyscOvWLQwePFhunRMnTqBWrVqYMWOGtEzepe7atWujdu3amDBhAgYOHIioqCj07t0bmpqaKnvL7QqTJOzYsQNpaWnw9fUFAKSkpEBTU7PI3FRzc3OkpKS8s52wsDCEhoaWYaRERFRWcnNzpX/jnz9/juXLlyMzMxPdu3d/5z6hoaEYO3YsDA0N0blzZ+Tm5iIuLg7Pnz9HYGAgHB0dcffuXWzatAmff/45/vrrL5legpcvX2Ly5Mn48ssvYWtri/v37+Ps2bPw8vIC8HoMQ2ZmJmJjY9GgQQPo6OiozM2zKkySsGbNGnTp0gVWVlYf1U5QUBACAwOlzzMyMmBtbf2x4RERfdI+lRUQ9+zZA0tLSwCvZyQ4OTlh69ataNu2LW7fvi13n2HDhkFHRwfff/89Jk+eDF1dXbi4uGD8+PEAgB49emDChAkYPXo0cnNz0bVrV8yaNUs6lVFdXR1Pnz6Ft7c3Hj9+DFNTU/Tp00f6g7NFixYYNWoU+vfvj6dPnyI4OFhlpkGKBEEQlB3EnTt3YGdnh+3bt6Nnz54AgH/++QcdOnTA8+fPZXoTatWqhfHjx2PChAnFajsjIwOGhoZIT0+HgYFBWYRPpLJO/HFV2SEoVIuedZUdQrG87+9aTk4OkpOTYWtr+95bAJNqK+7npEIsphQVFYVq1aqha9f/Zbqurq7Q0NBAbGystCwxMRF3796Fm5ubMsIkIiJSKUq/3CCRSBAVFQUfHx9UqfK/cAwNDeHn54fAwEAYGxvDwMAAY8aMgZub2zsHLRJR+bqw+93jgz5Fn0pPAlF5UXqScODAAdy9exdDhw4tsm3x4sVQU1ODl5eXzGJKREREVPaUniR06tQJ7xoWoaWlhRUrVmDFihXlHBUREREpPUkgok9XQKNEZYegYO2VHQBRhVIhBi4SERFRxcMkgYiIiORikkBERERyMUkgIiIiuThwkYhIBfx+6nG5Hq93c/NyPR6VDfYkEBFRhZGSkoIxY8bAzs4OYrEY1tbW6N69u3T1XRsbG4hEIultoAuNHz8ebdu2lT7Pzs5GUFAQ7O3toaWlBTMzM7Rp0wZ//PFHeZ7OJ489CUREVCHcvn0b7u7uMDIywvfffw8XFxfk5+dj7969CAgIwLVr1wC8XkNn6tSpOHz48DvbGjVqFE6fPo1ly5ahbt26ePr0KU6cOIGnT5+W1+lUCkwSiIioQvD394dIJMKZM2egq6srLa9Xr57MqrwjRozAqlWr8Pfff+OLL76Q29bOnTuxZMkS6XYbGxu4urqW7QlUQrzcQERESvfs2TPs2bMHAQEBMglCoTfvBmxra4tRo0YhKCgIEolEbnsWFhb4+++/8eLFi7IKWSUwSSAiIqW7efMmBEGAk5NTserPnDkTycnJWL9+vdztP/74I06cOAETExN8/vnnmDBhAo4fP67IkFUCkwQiIlK6d93D513MzMwwadIkzJ49G3l5eUW2t27dGrdu3UJsbCy+/PJLXLlyBa1atcK3336rqJBVApMEIiJSOkdHR4hEIungxOIIDAzEy5cv33l3YA0NDbRq1QpTp07Fvn37MGfOHHz77bdykwqSj0kCEREpnbGxMTw9PbFixQpkZWUV2Z6WllakTE9PD7NmzcK8efOKNfagbt26ePXqFXJychQRskpgkkBERBXCihUrUFBQgKZNm+K3337DjRs3kJCQgKVLl8LNzU3uPiNGjIChoSE2bNggU962bVusXr0a586dw+3bt/H3339j+vTpaNeuHQwMDMrjdCoFToEkIlIBn8IKiHZ2djh//jzmzZuHiRMn4tGjRzAzM4OrqysiIyPl7qOhoYFvv/0WgwYNkin39PRETEwMpk+fjuzsbFhZWaFbt26YPXt2eZxKpSESSjpa5BOTkZEBQ0NDpKenM3skUrTV8v9wf7JGfqPsCIrlfX/XcnJykJycDFtbW2hpaSkpQqroivs54eUGIiIikotJAhEREcnFMQlEVGoJi5cqOwSFcv5ELjcQlRf2JBAREZFcTBKIiIhILiYJREREJBeTBCIiIpKLSQIRERHJxSSBiIiI5OIUSCIiVRBiWM7HSy/f473DoUOH0K5dOzx//hxGRkZldpyQkBDs2LED8fHxZXYMZVB6T8KDBw/w1VdfwcTEBNra2nBxcUFcXJx0uyAImD17NiwtLaGtrQ0PDw/cuHFDiRETEVFZ8PX1hUgkKvLo3LmzskP7oEmTJiE2NlbZYSicUnsSnj9/Dnd3d7Rr1w67d++GmZkZbty4gapVq0rrLFy4EEuXLkVMTAxsbW0xa9YseHp64urVq1yXnIiokuncuTOioqJkysRisZKi+TBBEFBQUAA9PT3o6ekpOxyFU2pPwoIFC2BtbY2oqCg0bdoUtra26NSpE+zt7QG8fvEjIiIwc+ZM9OzZE/Xr18e6devw8OFD7NixQ5mhExFRGRCLxbCwsJB5FP5wFIlE+Pnnn9G7d2/o6OjA0dERO3fulNn/77//Ru3ataGtrY127drh9u3bRY7x22+/oV69ehCLxbCxscGiRYtktufm5mLq1KmwtraGWCyGg4MD1qxZA+D15QuRSITdu3fD1dUVYrEYx44dQ0hICBo2bChtw9fXF7169cIPP/wAS0tLmJiYICAgAPn5+TLHmTRpEqpXrw5dXV00a9YMhw4dUswLqSBKTRJ27tyJJk2aoG/fvqhWrRoaNWqEn376Sbo9OTkZKSkp8PDwkJYZGhqiWbNmOHnypNw2c3NzkZGRIfMgIqLKITQ0FP369cOlS5fwxRdfYPDgwXj27BkA4N69e+jTpw+6d++O+Ph4DBs2DNOmTZPZ/9y5c+jXrx8GDBiAy5cvIyQkBLNmzUJ0dLS0jre3NzZu3IilS5ciISEBq1evLtJLMG3aNHz33XdISEhA/fr15cZ68OBBJCUl4eDBg4iJiUF0dLTMcUaPHo2TJ09i06ZNuHTpEvr27YvOnTtXqEvqSk0Sbt26hcjISDg6OmLv3r345ptvMHbsWMTExAAAUlJSAADm5rL3QTc3N5due1tYWBgMDQ2lD2tr67I9CSIiUphdu3ZJu+4LH/Pnz5du9/X1xcCBA+Hg4ID58+cjMzMTZ86cAQBERkbC3t4eixYtQp06dTB48GD4+vrKtB8eHo4OHTpg1qxZqF27Nnx9fTF69Gh8//33AIDr169jy5YtWLt2LXr37g07Ozt06NAB/fv3l2lnzpw56NixI+zt7WFsbCz3XKpWrYrly5fDyckJ3bp1Q9euXaXjFu7evYuoqChs3boVrVq1gr29PSZNmoSWLVsWudyiTEodkyCRSNCkSRPpB6BRo0b4999/sWrVKvj4+JSqzaCgIAQGBkqfZ2RkMFEgIvpEtGvXDpGRkTJlb34Jv/mrXVdXFwYGBkhNTQUAJCQkoFmzZjL7urm5yTxPSEhAz549Zcrc3d0RERGBgoICxMfHQ11dHW3atHlvnE2aNPngudSrVw/q6urS55aWlrh8+TIA4PLlyygoKEDt2rVl9snNzYWJickH2y4vSk0SLC0tUbduXZkyZ2dn/PbbbwAACwsLAMDjx49haWkprfP48WOZaz9vEovFFXqQCxERvZuuri4cHBzeuV1DQ0PmuUgkgkQiUdjxtbW1i1VPV1f3g3XeF2tmZibU1dVx7tw5mUQCQIUaAKnUyw3u7u5ITEyUKbt+/Tpq1aoFALC1tYWFhYXMtJKMjAycPn26SHZIRESqzdnZWXrpodCpU6eK1Dl+/LhM2fHjx1G7dm2oq6vDxcUFEokEhw8fLtNYGzVqhIKCAqSmpsLBwUHmUfgDuSJQapIwYcIEnDp1CvPnz8fNmzexYcMG/PjjjwgICADwOusaP3485s6di507d+Ly5cvw9vaGlZUVevXqpczQiYioDOTm5iIlJUXm8d9//xVr31GjRuHGjRuYPHkyEhMTsWHDBpmBggAwceJExMbG4ttvv8X169cRExOD5cuXY9KkSQAAGxsb+Pj4YOjQodixYweSk5Nx6NAhbNmyRaHnWbt2bQwePBje3t7Yvn07kpOTcebMGYSFheGvv/5S6LE+hlIvN3z++ef4/fffERQUhDlz5sDW1hYREREYPHiwtM6UKVOQlZWFESNGIC0tDS1btsSePXu4RgIRUUlUkBUQP2TPnj0yl5cBoE6dOrh27doH961ZsyZ+++03TJgwAcuWLUPTpk0xf/58DB06VFqncePG2LJlC2bPno1vv/0WlpaWmDNnjswAx8jISEyfPh3+/v54+vQpatasienTpyvsHAtFRUVh7ty5mDhxIh48eABTU1M0b94c3bp1U/ixSkskCIKg7CDKUkZGBgwNDZGeng4DAwNlh0NUqSQ4OSs7BIVyvpag7BCK5X1/13JycpCcnAxbW1v+mKJ3Ku7nROnLMhMREVHFxCSBiIiI5GKSQERERHIxSSAiIiK5mCQQERGRXCVOEs6fPy9dVhIA/vjjD/Tq1QvTp09HXl6eQoMjIiIi5SlxkjBy5Ehcv34dwOsbNA0YMAA6OjrYunUrpkyZovAAiYiISDlKnCRcv35det+ErVu3onXr1tJVrQrvuUBERESfvhInCYIgSG9QceDAAXzxxRcAAGtr62IvnUlEREQVX4mXZW7SpAnmzp0LDw8PHD58WHpLz+TkZJibmys8QCIiUoADQeV7PI+w8j0elYkS9yRERETg/PnzGD16NGbMmCG9pee2bdvQokULhQdIRESqIyUlBePGjYODgwO0tLRgbm4Od3d3REZGIjs7G8DrmzBFREQoN1AVUeKehPr168vMbij0/fffF7knNhERUXHdunUL7u7uMDIywvz58+Hi4gKxWIzLly/jxx9/RPXq1dGjRw9lh6lSSnUXyLS0NGzbtg1JSUmYPHkyjI2NcfXqVZibm6N69eqKjpGIiFSAv78/qlSpgri4OOjq6krL7ezs0LNnT1Ty+xFWSCVOEi5duoQOHTrAyMgIt2/fxvDhw2FsbIzt27fj7t27WLduXVnESUREldjTp0+xb98+zJ8/XyZBeJNIJCrnqKjEYxICAwMxZMgQ3LhxQ+b2kl988QWOHDmi0OCIiEg13Lx5E4IgoE6dOjLlpqam0NPTg56eHqZOnaqk6FRXiZOEs2fPYuTIkUXKq1evjpSUFIUERUREBABnzpxBfHw86tWrh9zcXGWHo3JKfLlBLBYjIyOjSPn169dhZmamkKCI6NNwZM9QZYegUM7KDkCFOTg4QCQSITExUabczs4OAKCtra2MsFReiXsSevTogTlz5iA/Px/A62tEd+/exdSpU+Hl5aXwAImIqPIzMTFBx44dsXz5cmRlZSk7HPp/JU4SFi1ahMzMTFSrVg0vX75EmzZt4ODgAH19fcybN68sYiQiIhWwcuVKvHr1Ck2aNMHmzZuRkJCAxMRE/Prrr7h27Rqn2StBiS83GBoaYv/+/Th27BguXbqEzMxMNG7cGB4eHmURHxERKcInsAKivb09Lly4gPnz5yMoKAj379+HWCxG3bp1MWnSJPj7+ys7RJVTqnUSAKBly5Zo2bKlImMhIiIVZ2lpiWXLlmHZsmXvrHP79u3yC0jFFStJWLp0KUaMGAEtLS0sXbr0vXXHjh2rkMCIiIhIuYqVJCxevBiDBw+GlpYWFi9e/M56IpGISQIREVElUawkITk5We6/iUi1LT9cuVZYHWkzWdkhEFUoJZrdkJ+fD3t7eyQkJJRVPERERFRBlChJ0NDQQE5OTlnFQkRERBVIiddJCAgIwIIFC/Dq1auyiIeIiIgqiFLdu2H79u2oWbMmPD090adPH5lHSYSEhEAkEsk8nJycpNtzcnIQEBAAExMT6OnpwcvLC48fPy5pyERERFQKJV4nwcjISKHLL9erVw8HDhz4X0BV/hfShAkT8Ndff2Hr1q0wNDTE6NGj0adPHxw/flxhxyciIiL5SpwkREVFKTaAKlVgYWFRpDw9PR1r1qzBhg0b0L59e+mxnZ2dcerUKTRv3lyhcRAREZGsUq24+OrVKxw6dAhJSUkYNGgQ9PX18fDhQxgYGEBPT69Ebd24cQNWVlbQ0tKCm5sbwsLCULNmTZw7dw75+fkyyz07OTmhZs2aOHny5DuThNzcXJnbicq7YyURkapxiXEp1+Nd9rlcrsejslHiMQl37tyBi4sLevbsiYCAADx58gQAsGDBAkyaNKlEbTVr1gzR0dHYs2cPIiMjkZycjFatWuHFixdISUmBpqYmjIyMZPYxNzdHSkrKO9sMCwuDoaGh9GFtbV3SUyQiIiVJSUnBuHHj4ODgAC0tLZibm8Pd3R2RkZHIzs4G8Hrhvh07dhTZ19fXF7169SrfgCu5EvckjBs3Dk2aNMHFixdhYmIiLe/duzeGDx9eora6dOki/Xf9+vXRrFkz1KpVC1u2bCn1vcODgoIQGBgofZ6RkcFEgYjoE3Dr1i24u7vDyMgI8+fPh4uLC8RiMS5fvowff/wR1atXR48ePZQdpkopcZJw9OhRnDhxApqamjLlNjY2ePDgwUcFY2RkhNq1a+PmzZvo2LEj8vLykJaWJtOb8PjxY7ljGAqJxWKIxeKPioOIiMqfv78/qlSpgri4OOjq6krL7ezs0LNnTwiCoMToVFOJLzdIJBIUFBQUKb9//z709fU/KpjMzEwkJSXB0tISrq6u0NDQQGxsrHR7YmIi7t69Czc3t486DhERVSxPnz7Fvn37EBAQIJMgvEkkEpVzVFTiJKFTp06IiIiQPheJRMjMzERwcDC++OKLErU1adIkHD58GLdv38aJEyfQu3dvqKurY+DAgTA0NISfnx8CAwNx8OBBnDt3DkOGDIGbmxtnNhARVTI3b96EIAioU6eOTLmpqSn09PSgp6eHqVOnKik61VXiyw2LFi2Cp6cn6tati5ycHAwaNAg3btyAqakpNm7cWKK27t+/j4EDB+Lp06cwMzNDy5YtcerUKZiZmQF4ffdJNTU1eHl5ITc3F56enli5cmVJQyYiok/UmTNnIJFIMHjwYJmZa1Q+Spwk1KhRAxcvXsSmTZtw6dIlZGZmws/PD4MHDy7xYMNNmza9d7uWlhZWrFiBFStWlDRMIiL6hDg4OEAkEiExMVGm3M7ODgBkvl/09fWRnp5epI20tDQYGhqWbaAqplTrJFSpUgVfffWVomMhIiIVZWJigo4dO2L58uUYM2bMO8clAECdOnVw7tw5+Pj4SMsKCgpw8eJFDBs2rDzCVRklThLWrXv//eO9vb1LHQwREamulStXwt3dHU2aNEFISAjq168PNTU1nD17FteuXYOrqysAIDAwEH5+fnByckLHjh2RlZWFZcuW4fnz50wSFKxU6yS8KT8/H9nZ2dDU1ISOjg6TBCKiCuhTWAHR3t4eFy5cwPz58xEUFIT79+9DLBajbt26mDRpEvz9/QEAAwcOhCAICA8Px7Rp06CjowNXV1ccOXIE5ubmSj6LyqXEScLz58+LlN24cQPffPMNJk+erJCgiIhINVlaWmLZsmVYtmzZe+sNGjQIgwYNKqeoVFeJp0DK4+joiO+++65ILwMRERF9uhSSJACvBzM+fPhQUc0RERGRkpX4csPOnTtlnguCgEePHmH58uVwd3dXWGBERESkXCVOEt6+w5ZIJIKZmRnat2+PRYsWKSouIiIiUrISJwkSiaQs4iAiIqIKRmFjEoiIiKhyKXFPQmBgYLHrhoeHl7R5IiIiqiBKnCRcuHABFy5cQH5+vvRuXdevX4e6ujoaN24srcdbehIREX3aSpwkdO/eHfr6+oiJiUHVqlUBvF5gaciQIWjVqhUmTpyo8CCJiIio/JXqVtH79u2TJggAULVqVcydOxedOnVikkBEVAGtvv19uR5vpA1X4K0MSjxwMSMjA0+ePClS/uTJE7x48UIhQRERkWpKSUnBuHHj4ODgAC0tLZibm8Pd3R2RkZFo3749PD09i+yzcuVKGBkZ4f79+zh06BBEIhHq1auHgoICmXpGRkaIjo4upzOpHEqcJPTu3RtDhgzB9u3bcf/+fdy/fx+//fYb/Pz80KdPn7KIkYiIVMCtW7fQqFEj7Nu3D/Pnz8eFCxdw8uRJTJkyBbt27YKPjw9Onz6N1atXS/dJTk7GlClTsGzZMtSoUUOmrQ/dtZg+rMSXG1atWoVJkyZh0KBByM/Pf91IlSrw8/PD99+Xb3cWERFVHv7+/qhSpQri4uKgq6srLbezs0PPnj0hCAIAYPTo0ejUqRNsbGzg5+eHTp064euvv5Zpa8yYMQgODsagQYMgFovL9TwqkxL3JOjo6GDlypV4+vSpdKbDs2fPsHLlSpk3lYiIqLiePn2Kffv2ISAg4J3fJSKRCD4+PujQoQOGDh2K5cuX499//5XpWSg0fvx4vHr16oN3k6T3K/ViSrq6uqhfvz7q16/P5ICIiD7KzZs3IQiCdGp9IVNTU+jp6UFPTw9Tp04FAPz444/4999/MX78ePz4448wMzMr0p6Ojg6Cg4MRFhaG9PT0cjmHyogrLhIRUYV15swZxMfHo169esjNzQUAVKtWDSNHjoSzs3OR+wm9yc/PDyYmJliwYEE5RVv5MEkgIiKlc3BwgEgkQmJioky5nZ0dHBwcoK2tLVNepUoVVKny/mF1VapUwbx587BkyRI8fPhQ4TGrAiYJRESkdCYmJujYsSOWL1+OrKwshbXbt29f1KtXD6GhoQprU5UUK0lo3Lgxnj9/DgCYM2cOsrOzyzQoIiJSPStXrsSrV6/QpEkTbN68GQkJCUhMTMSvv/6Ka9euQV1dvVTtfvfdd1i7dq1Ckw9VUawpkAkJCcjKykLVqlURGhqKUaNGQUdHp6xjIyIiBfkUVkC0t7fHhQsXMH/+fAQFBeH+/fsQi8WoW7cuJk2aBH9//1K12759e7Rv3x779u1TcMSVn0gonHj6Hm5ubtDT00PLli0RGhqKSZMmQU9PT27d2bNnKzzIj5GRkQFDQ0Okp6fDwMBA2eEQVSouMS7KDkGhLvtcVnYIxfK+v2s5OTlITk6Gra0ttLS0lBQhVXTF/ZwUqychOjoawcHB2LVrF0QiEXbv3i13wIhIJKpwSQIRERGVTrGShDp16mDTpk0AADU1NcTGxqJatWplGhgREREpV4lnN0gkkjJJEL777juIRCKMHz9eWpaTk4OAgACYmJhAT08PXl5eePz4scKPTUREREWVagpkUlISxowZAw8PD3h4eGDs2LFISkoqdRBnz57F6tWrUb9+fZnyCRMm4M8//8TWrVtx+PBhPHz4kDeRIiIiKiclThL27t2LunXr4syZM9JlmU+fPo169eph//79JQ4gMzMTgwcPxk8//YSqVatKy9PT07FmzRqEh4ejffv2cHV1RVRUFE6cOIFTp06V+DhERERUMiVOEqZNm4YJEybg9OnTCA8PR3h4OE6fPo3x48dL19UuiYCAAHTt2hUeHh4y5efOnUN+fr5MuZOTE2rWrImTJ0++s73c3FxkZGTIPIiIiKjkSpwkJCQkwM/Pr0j50KFDcfXq1RK1tWnTJpw/fx5hYWFFtqWkpEBTUxNGRkYy5ebm5khJSXlnm2FhYTA0NJQ+rK2tSxQTERERvVbiJMHMzAzx8fFFyuPj40s0oPHevXsYN24c1q9fr9C5vEFBQUhPT5c+7t27p7C2iYiIVEmxpkC+afjw4RgxYgRu3bqFFi1aAACOHz+OBQsWIDAwsNjtnDt3DqmpqWjcuLG0rKCgAEeOHMHy5cuxd+9e5OXlIS0tTaY34fHjx7CwsHhnu2KxGGKxuKSnRURERG8pcZIwa9Ys6OvrY9GiRQgKCgIAWFlZISQkBGPHji12Ox06dMDly7Krmw0ZMgROTk6YOnUqrK2toaGhgdjYWHh5eQEAEhMTcffuXbi5uZU0bCIilZbg5Fyux3O+llCux6vI2rZti4YNGyIiIkJhbYaEhGDHjh1ye/YVqcRJgkgkwoQJEzBhwgS8ePECAKCvr1/iA+vr6+Ozzz6TKdPV1YWJiYm03M/PD4GBgTA2NoaBgQHGjBkDNzc3NG/evMTHIyKiis3X1xdpaWnYsWOHTPmhQ4fQrl07PH/+vMg4tfJUFl/2pTVp0iSMGTOmzI9T4iThTaVJDkpi8eLFUFNTg5eXF3Jzc+Hp6YmVK1eW6TGJiIgqOj09vXfeQ0mRSrWYUlk5dOiQTIampaWFFStW4NmzZ8jKysL27dvfOx6BiIgqv2PHjqFVq1bQ1taGtbU1xo4dK3MbaBsbG8ydOxfe3t7Q09NDrVq1sHPnTjx58gQ9e/aEnp4e6tevj7i4OOk+T58+xcCBA1G9enXo6OjAxcUFGzdulG739fXF4cOHsWTJEohEIohEIty+fRsAcPjwYTRt2hRisRiWlpaYNm0aXr169c74nz9/Dm9vb1StWhU6Ojro0qULbty4IVPnp59+grW1NXR0dNC7d2+Eh4fL9KKEhISgYcOGMvusXbsW9erVk8YxevToUry6sipUkkBERPQ+SUlJ6Ny5M7y8vHDp0iVs3rwZx44dK/KFuHjxYri7u+PChQvo2rUrvv76a3h7e+Orr77C+fPnYW9vD29vbxTeCDknJweurq7466+/8O+//2LEiBH4+uuvcebMGQDAkiVL4ObmhuHDh+PRo0d49OgRrK2t8eDBA3zxxRf4/PPPcfHiRURGRmLNmjWYO3fuO8/B19cXcXFx2LlzJ06ePAlBEPDFF18gPz8fwOvJAKNGjcK4ceMQHx+Pjh07Yt68ee99XSIjIxEQEIARI0bg8uXL2LlzJxwcHD7mpQbwkZcbiIiIFGnXrl1FutELCgqk/w4LC8PgwYOl9/lxdHTE0qVL0aZNG0RGRkqn1H/xxRcYOXIkAGD27NmIjIzE559/jr59+wIApk6dCjc3N+mMuerVq2PSpEnS44wZMwZ79+7Fli1b0LRpUxgaGkJTUxM6OjoyPdorV66EtbU1li9fDpFIBCcnJzx8+BBTp07F7NmzoaYm+1v8xo0b2LlzJ44fPy6dIbh+/XpYW1tjx44d6Nu3L5YtW4YuXbpI46lduzZOnDiBXbt2vfN1mzt3LiZOnIhx48ZJyz7//PPivejvUaKehPz8fHTo0KFItwgREZEitGvXDvHx8TKPn3/+Wbr94sWLiI6Oll6T19PTg6enJyQSCZKTk6X13rwXkLm5OQDAxcWlSFlqaiqA14nIt99+CxcXFxgbG0NPTw979+7F3bt33xtvQkIC3NzcIBKJpGXu7u7IzMzE/fv35davUqUKmjVrJi0zMTFBnTp1kJDwekZIYmIimjZtKrPf28/flJqaiocPH6JDhw7vjbU0StSToKGhgUuXLik8CCIiIuD1LLe3u8nf/LLNzMzEyJEj5U65r1mzpvTfGhoa0n8XfoHLK5NIJACA77//HkuWLEFERARcXFygq6uL8ePHIy8vTwFnVba0tbXLrO0Sj0n46quvsGbNmrKIhYiI6L0aN26Mq1evwsHBochDU1Oz1O0eP34cPXv2xFdffYUGDRrAzs4O169fl6mjqakpc+kDAJydnaXjCt5sS19fHzVq1ChyHGdnZ7x69QqnT5+Wlj19+hSJiYmoW7cuAKBOnTo4e/aszH5vP3+Tvr4+bGxsEBsbW/wTLqYSj0l49eoV1q5diwMHDsDV1RW6uroy28PDwxUWHBER0ZumTp2K5s2bY/To0Rg2bBh0dXVx9epV7N+/H8uXLy91u46Ojti2bRtOnDiBqlWrIjw8HI8fP5Z+cQOvZ02cPn0at2/fhp6eHoyNjeHv74+IiAiMGTMGo0ePRmJiIoKDgxEYGFhkPELhcXr27Inhw4dj9erV0NfXx7Rp01C9enX07NkTwOvxEK1bt0Z4eDi6d++Of/75B7t375a5pPG2kJAQjBo1CtWqVUOXLl3w4sULHD9+/KPXUihxkvDvv/9Kl1J+O8t63wkQEZHyVJYVEOvXr4/Dhw9jxowZaNWqFQRBgL29Pfr37/9R7c6cORO3bt2Cp6cndHR0MGLECPTq1Qvp6enSOpMmTYKPjw/q1q2Lly9fIjk5GTY2Nvj7778xefJkNGjQAMbGxvDz88PMmTPfeayoqCiMGzcO3bp1Q15eHlq3bo2///5bejnE3d0dq1atQmhoKGbOnAlPT09MmDDhvUmQj48PcnJysHjxYkyaNAmmpqb48ssvP+o1AQCR8GYfSSWUkZEBQ0NDpKenw8DAQNnhEFUqLjEuH670Cbnsc/nDlSqA9/1dy8nJQXJyMmxtbRV68zxSruHDh+PatWs4evSoQtor7uek1FMgb968iaSkJLRu3Rra2toQBIE9CURERArwww8/oGPHjtDV1cXu3bsRExOjlBWHS5wkPH36FP369cPBgwchEolw48YN2NnZwc/PD1WrVsWiRYvKIk4iIiKVcebMGSxcuBAvXryAnZ0dli5dimHDhpV7HCWe3TBhwgRoaGjg7t270NHRkZb3798fe/bsUWhwREREqmjLli1ITU3Fy5cvceXKFYwaNUopcZS4J2Hfvn3Yu3dvkakdjo6OuHPnjsICIyIiIuUqcZKQlZUl04NQ6NmzZxCLxQoJiog+DZerd1N2CERUhkp8uaFVq1ZYt26d9LlIJIJEIsHChQvRrl07hQZHREREylPinoSFCxeiQ4cOiIuLQ15eHqZMmYIrV67g2bNnOH78eFnESEREREpQ4p6Ezz77DNevX0fLli3Rs2dPZGVloU+fPrhw4QLs7e3LIkYiIiJSglKtk2BoaIgZM2YoOhYiIiKqQEqVJDx//hxr1qyR3taybt26GDJkCIyNjRUaHBERKcjqyPI93shvyvd4VCZKfLnhyJEjsLGxwdKlS/H8+XM8f/4cS5cuha2tLY4cOVIWMRIRkQrw9fVFr169lB0GvaHEPQkBAQHo378/IiMjoa6uDgAoKCiAv78/AgICcPnyp7H2OREREb1fiXsSbt68iYkTJ0oTBABQV1dHYGAgbt68qdDgiIiIoqOjYWRkJFO2Y8cOmfsFhYSEoGHDhvjll19gY2MDQ0NDDBgwAC9evJDWefHiBQYPHgxdXV1YWlpi8eLFaNu2LcaPH19OZ/LpKXGS0LhxY+lYhDclJCSgQYMGCgmKiIiopJKSkrBjxw7s2rULu3btwuHDh/Hdd99JtwcGBuL48ePYuXMn9u/fj6NHj+L8+fNKjLjiK9blhkuXLkn/PXbsWIwbNw43b95E8+bNAQCnTp3CihUrZN4MIiKi8iSRSBAdHQ19fX0AwNdff43Y2FjMmzcPL168QExMDDZs2IAOHToAAKKiomBlZaXMkCu8YiUJDRs2hEgkgiAI0rIpU6YUqTdo0CD0799fcdEREREVk42NjTRBAABLS0ukpqYCAG7duoX8/Hw0bdpUut3Q0BB16tQp9zg/JcVKEpKTk8s6DiIiIrnU1NRkfqQCQH5+fpF6GhoaMs8LbxtApVesJKFWrVplHQcREZFcZmZmePHiBbKysqCrqwsAiI+PL1EbdnZ20NDQwNmzZ1GzZk0AQHp6Oq5fv47WrVsrOuRKo1SLKT18+BDHjh1DampqkSxt7NixCgmMiIhUT3p6epEEoG7dutDR0cH06dMxduxYnD59GtHR0SVqV19fHz4+Ppg8eTKMjY1RrVo1BAcHQ01NTWaWBMkqcZIQHR2NkSNHQlNTEyYmJjIvrkgkYpJARFQRfSIrIB46dAiNGjWSKfPz88Ovv/6KyZMn46effkKHDh0QEhKCESNGlKjt8PBwjBo1Ct26dYOBgQGmTJmCe/fuQUtLS5GnUKmIhLcv9HyAtbU1Ro0ahaCgIKiplXgGpYzIyEhERkbi9u3bAIB69eph9uzZ6NKlCwAgJycHEydOxKZNm5CbmwtPT0+sXLkS5ubmxT5GRkYGDA0NkZ6eDgMDg4+Kl4jeciBI2REolkeYsiMolvf9XcvJyUFycjJsbW355fcBWVlZqF69OhYtWgQ/Pz9lh1Ouivs5KfG3fHZ2NgYMGPDRCQIA1KhRA9999x3OnTuHuLg4tG/fHj179sSVK1cAABMmTMCff/6JrVu34vDhw3j48CH69Onz0cclIiLVc+HCBWzcuBFJSUk4f/48Bg8eDADo2bOnkiOruEp8ucHPzw9bt27FtGnTPvrg3bt3l3k+b948REZG4tSpU6hRowbWrFmDDRs2oH379gBez2l1dnbGqVOnpGs0vC03Nxe5ubnS5xkZGR8dJxERVQ4//PADEhMToampCVdXVxw9ehSmpqbKDqvCKnGSEBYWhm7dumHPnj1wcXEpMuUkPDy8VIEUFBRg69atyMrKgpubG86dO4f8/Hx4eHhI6zg5OaFmzZo4efLkO5OEsLAwhIaGlioGIiKqvBo1aoRz584pO4xPSqmShL1790oXoHh74GJJXb58GW5ubsjJyYGenh5+//131K1bF/Hx8dDU1CyyXre5uTlSUlLe2V5QUBACAwOlzzMyMmBtbV3iuIiIiFRdiZOERYsWYe3atfD19VVIAHXq1EF8fDzS09Oxbds2+Pj44PDhw6VuTywWQywWKyQ2IiIiVVbiJEEsFsPd3V1hAWhqasLBwQEA4OrqirNnz2LJkiXo378/8vLykJaWJtOb8PjxY1hYWCjs+ERERCRfiacojBs3DsuWLSuLWAC8vkFHbm4uXF1doaGhgdjYWOm2xMRE3L17F25ubmV2fCIiInqtxD0JZ86cwT///INdu3ahXr16RQYubt++vdhtBQUFoUuXLqhZsyZevHiBDRs24NChQ9i7dy8MDQ3h5+eHwMBAGBsbw8DAAGPGjIGbm9s7By0SERGR4pQ4STAyMlLYWgWpqanw9vbGo0ePYGhoiPr162Pv3r3o2LEjAGDx4sVQU1ODl5eXzGJKREREVPZKvOLip4YrLhKVIa64qBSlWXFxxah/yjXGgFXty/V40dHRGD9+PNLS0sr1uJ+qMltxkYiIqKzcu3cPQ4cOhZWVFTQ1NVGrVi2MGzcOT58+ldaxsbFBRESE8oJUISW+3GBra/ve9RBu3br1UQEREZFqunXrFtzc3FC7dm1s3LgRtra2uHLlCiZPnozdu3fj1KlTMDY2LteY8vPzi4y9UyUl7kkYP348xo0bJ334+/vDzc0N6enpJb4jFxERUaGAgABoampi3759aNOmDWrWrIkuXbrgwIEDePDgAWbMmIG2bdvizp07mDBhAkQiUZEfrXv37oWzszP09PTQuXNnPHr0SGb7zz//DGdnZ2hpacHJyUlmnNvt27chEomwefNmtGnTBlpaWli/fn25nHtFVeKehHHjxsktX7FiBeLi4j46ICIiUj3Pnj3D3r17MW/ePGhra8tss7CwwODBg7F582bcuHEDDRs2xIgRIzB8+HCZetnZ2fjhhx/wyy+/QE1NDV999RUmTZok/aJfv349Zs+ejeXLl6NRo0a4cOEChg8fDl1dXfj4+EjbmTZtGhYtWoRGjRqp/J00S5wkvEuXLl0QFBSEqKgoRTVJREQq4saNGxAEAc7OznK3Ozs74/nz5ygoKIC6ujr09fWLLKyXn5+PVatWwd7eHgAwevRozJkzR7o9ODgYixYtks7Qs7W1xdWrV7F69WqZJGH8+PG84/D/U1iSsG3btnK/VkRERJXLx0y409HRkSYIAGBpaYnU1FQAQFZWFpKSkuDn5yfTA/Hq1SsYGhrKtNOkSZNSx1DZlDhJaNSokcw1IEEQkJKSgidPnnANAyIiKhUHBweIRCIkJCSgd+/eRbYnJCSgatWqMDMze2cbbw8wFIlE0qQjMzMTAPDTTz+hWbNmMvXU1dVlnuvq6pbqHCqjEicJvXr1knmupqYGMzMztG3bFk5OToqKi4iIVIiJiQk6duyIlStXYsKECTLjElJSUrB+/Xp4e3tDJBJBU1MTBQUFJWrf3NwcVlZWuHXrFgYPHqzo8CutEicJwcHBZREHERGpuOXLl6NFixbw9PTE3LlzZaZAVq9eHfPmzQPwep2EI0eOYMCAARCLxTA1NS1W+6GhoRg7diwMDQ3RuXNn5ObmIi4uDs+fP0dgYGBZntonS2FjEoiIqOIq7xUQS8PR0RFxcXEIDg5Gv3798OzZM1hYWKBXr14IDg6WjnubM2cORo4cCXt7e+Tm5hZ7HMOwYcOgo6OD77//HpMnT4auri5cXFwwfvz4MjyrT1uxl2VWU1N77yJKwOvrP69evVJIYIrCZZmJyhCXZVaK0izLTPSm4n5Oit2T8Pvvv79z28mTJ7F06VJIJJKSRUlFHF+zQtkhKJS7X4CyQyAiolIqdpLQs2fPImWJiYmYNm0a/vzzTwwePFhmPioRERF92kp1g6eHDx9i+PDhcHFxwatXrxAfH4+YmBjUqlVL0fERERGRkpQoSUhPT8fUqVPh4OCAK1euIDY2Fn/++Sc+++yzsoqPiIiIlKTYlxsWLlyIBQsWwMLCAhs3bpR7+YE+3ql9u5UdgkJxTAIR0aer2EnCtGnToK2tDQcHB8TExCAmJkZuve3btyssOCIiIlKeYicJhStdERERkWoodpIQHR1dhmEQERFRRcMVFysYt0ELlR0CERERACYJREQq4cQfV8v1eC161i3X41HZKNU6CURERIr25MkTfPPNN6hZsybEYjEsLCzg6emJ48ePKzs0lcWeBCIiqhC8vLyQl5eHmJgY2NnZ4fHjx4iNjcXTp09L1V5BQQFEIhHU1Ph7uLT4yhERkdKlpaXh6NGjWLBgAdq1a4datWqhadOmCAoKQo8ePQAA4eHhcHFxga6uLqytreHv74/MzExpG9HR0TAyMsLOnTtRt25diMVi3L17F7m5uZg6dSqsra0hFovh4OCANWvWSPc7fPgwmjZtCrFYDEtLS0ybNk3mZoVt27bFmDFjMH78eFStWhXm5ub46aefkJWVhSFDhkBfXx8ODg7Yvft/69wUFBTAz88Ptra20NbWRp06dbBkyZJyeCUVi0kCEREpnZ6eHvT09LBjxw7k5ubKraOmpoalS5fiypUriImJwT///IMpU6bI1MnOzsaCBQvw888/48qVK6hWrRq8vb2xceNGLF26FAkJCVi9ejX09PQAAA8ePMAXX3yBzz//HBcvXkRkZCTWrFmDuXPnyrQbExMDU1NTnDlzBmPGjME333yDvn37okWLFjh//jw6deqEr7/+GtnZ2QAAiUSCGjVqYOvWrbh69Spmz56N6dOnY8uWLWXw6pWdYt8q+lP1qd0qurwHF5U1Dl6q5HiraKUoza2iP4WBi7/99huGDx+Oly9fonHjxmjTpg0GDBiA+vXry62/bds2jBo1Cv/99x+A1z0JQ4YMQXx8PBo0aAAAuH79OurUqYP9+/fDw8OjSBszZszAb7/9hoSEBOlaQCtXrsTUqVORnp4ONTU1tG3bFgUFBTh69CiA170EhoaG6NOnD9atWwcASElJgaWlJU6ePInmzZvLjXf06NFISUnBtm3bSvzaKJrCbxVN5ePC7hRlh6BQTBKIqLi8vLzQtWtXHD16FKdOncLu3buxcOFC/Pzzz/D19cWBAwcQFhaGa9euISMjA69evUJOTg6ys7Oho6MDANDU1JRJKuLj46Guro42bdrIPWZCQgLc3NxkFgt0d3dHZmYm7t+/j5o1awKATJvq6uowMTGBi4uLtMzc3BwAkJqaKi1bsWIF1q5di7t37+Lly5fIy8tDw4YNP/6FKkdKvdwQFhaGzz//HPr6+qhWrRp69eqFxMREmTo5OTkICAiAiYkJ9PT04OXlhcePHyspYiIiKktaWlro2LEjZs2ahRMnTsDX1xfBwcG4ffs2unXrhvr16+O3337DuXPnsGLFCgBAXl6edH9tbW2ZL3xtbW2FxKWhoSHzXCQSyZQVHlMikQAANm3ahEmTJsHPzw/79u1DfHw8hgwZIhPrp0CpScLhw4cREBCAU6dOYf/+/cjPz0enTp2QlZUlrTNhwgT8+eef2Lp1Kw4fPoyHDx+iT58+SoyaiIjKS926dZGVlYVz585BIpFg0aJFaN68OWrXro2HDx9+cH8XFxdIJBIcPnxY7nZnZ2ecPHkSb155P378OPT19VGjRo1Sx338+HG0aNEC/v7+aNSoERwcHJCUlFTq9pRFqZcb9uzZI/M8Ojoa1apVw7lz59C6dWukp6djzZo12LBhA9q3bw8AiIqKgrOzM06dOiX3uk9ubq7MoJeMjIyyPQkiIvpoT58+Rd++fTF06FDUr18f+vr6iIuLw8KFC9GzZ084ODggPz8fy5YtQ/fu3XH8+HGsWrXqg+3a2NjAx8cHQ4cOxdKlS9GgQQPcuXMHqamp6NevH/z9/REREYExY8Zg9OjRSExMRHBwMAIDAz9q6qSjoyPWrVuHvXv3wtbWFr/88gvOnj0LW1vbUrepDBVqTEJ6ejoAwNjYGABw7tw55Ofnyww2cXJyQs2aNd85OCQsLAyhoaHlE3AZCGiU+OFKn5T2yg6AiFDxxwfp6emhWbNmWLx4MZKSkpCfnw9ra2sMHz4c06dPh7a2NsLDw7FgwQIEBQWhdevWCAsLg7e39wfbjoyMxPTp0+Hv74+nT5+iZs2amD59OgCgevXq+PvvvzF58mQ0aNAAxsbG8PPzw8yZMz/qfEaOHIkLFy6gf//+EIlEGDhwIPz9/WWmSX4KKszsBolEgh49eiAtLQ3Hjh0DAGzYsAFDhgwpMh2madOmaNeuHRYsWFCkHXk9CdbW1p/M7AasjlR2BIo18htlR0BlibMblKI0sxuI3vTJzW4ICAjAv//+K00QSkssFkMsFisoKiIiItVVIRZTGj16NHbt2oWDBw/KDBSxsLBAXl4e0tLSZOo/fvwYFhYW5RwlERGRalFqT4IgCBgzZgx+//13HDp0qMiADldXV2hoaCA2NhZeXl4AgMTERNy9exdubm7KCJmI3nRspbIjUKxP5HIDUXlRapIQEBCADRs24I8//oC+vj5SUl4vJGRoaAhtbW0YGhrCz88PgYGBMDY2hoGBAcaMGQM3N7d3rmhFREREiqHUJCEy8vUgvbZt28qUR0VFwdfXFwCwePFiqKmpwcvLC7m5ufD09MTKlZXs1wsREVEFpPTLDR+ipaWFFStWSFfWIiIiovJRYWY30GsJi5cqOwSFcuYUSCKiT1aFmN1AREREFQ+TBCIiIpKLlxuIiFTAov7dyvV4EzfvUnibIpEIv//+O3r16iV3u42NDcaPH4/x48cr/Niqij0JRERUITx58gTffPMNatasCbFYDAsLC3h6euL48ePF2v/s2bMYMWJEGUepWtiTQEREFYKXlxfy8vIQExMDOzs7PH78GLGxsXj69Gmx9jczMyvjCFUPexKIiEjp0tLScPToUSxYsADt2rVDrVq10LRpUwQFBaFHjx5y9wkODoalpSUuXboE4PXlhoiICOl2kUiEn3/+Gb1794aOjg4cHR2xc+fO8jidSoNJAhERKZ2enh709PSwY8eOInf+fVvhkv7r1q3D0aNHUb9+/XfWDQ0NRb9+/XDp0iV88cUXGDx4MJ49e6bo8CstJglERKR0VapUQXR0NGJiYmBkZAR3d3dMnz5d2ktQ6NWrV/jqq68QGxuLY8eOwcHB4b3t+vr6YuDAgXBwcMD8+fORmZmJM2fOlOWpVCpMEoiIqELw8vLCw4cPsXPnTnTu3BmHDh1C48aNER0dLa0zYcIEnD59GkeOHEH16tU/2OabvQy6urowMDBAampqWYRfKTFJICKiCkNLSwsdO3bErFmzcOLECfj6+iI4OFi6vWPHjnjw4AH27t1brPY0NDRknotEIkgkEoXGXJlxdkMF0y+ocr0ll5UdAJWp3ztfV3YICtVb2QFQEXXr1sWOHTukz3v06IHu3btj0KBBUFdXx4ABA5QXnAqoXN9IRET0SXr69Cn69u2LoUOHon79+tDX10dcXBwWLlyInj17ytTt3bs3fvnlF3z99deoUqUKvvzySyVFXfkxSSAiUgFlsQKiIunp6aFZs2ZYvHgxkpKSkJ+fD2trawwfPhzTp08vUv/LL7+ERCLB119/DTU1NfTp00cJUVd+TBKIiEjpxGIxwsLCEBYW9s46giDIPO/Xrx/69esnfX779u331gder8dAxceBi0RERCQXkwQiIiKSi0kCERERycUkgYiIiORikkBERERyMUkgIiIiuZgkEBERkVxMEoiIiEguJglEREQkF1dcJCJSAcfXrCjX47n7BZTr8SqStm3bomHDhoiIiAAAZGdn4+uvv8b+/fvx4sULPH/+HA0bNsT48eMxfvz4Uh8nJCQEO3bsQHx8vELilodJAhERVQhvf7kWio6Oxvjx4z+ZJZW3b98uc4vqmJgYHD16FCdOnICpqSkMDQ1x9uxZ6OrqKjHK4mGSQEREpEDGxsYyz5OSkuDs7IzPPvtMWmZmZlbeYZWKUsckHDlyBN27d4eVlRVEIpHMPcOB1zfnmD17NiwtLaGtrQ0PDw/cuHFDOcESEZHS+fr6olevXvjhhx9gaWkJExMTBAQEID8/X1pn5cqVcHR0hJaWFszNzWVuJd22bVuMHj0ao0ePhqGhIUxNTTFr1iyZm0Hl5uZi0qRJqF69OnR1ddGsWTMcOnRIJo7jx4+jbdu20NHRQdWqVeHp6Ynnz59Lj1F4GaFt27ZYtGgRjhw5ApFIhLZt2wIAbGxsZHpM0tLSMGzYMJiZmcHAwADt27fHxYsXZY753XffwdzcHPr6+vDz80NOTo4CXtH3U2qSkJWVhQYNGmDFCvnXyhYuXIilS5di1apVOH36NHR1deHp6VkuLwwREVVMBw8eRFJSEg4ePIiYmBhER0cjOjoaABAXF4exY8dizpw5SExMxJ49e9C6dWuZ/WNiYlClShWcOXMGS5YsQXh4OH7++Wfp9tGjR+PkyZPYtGkTLl26hL59+6Jz587SH6nx8fHo0KED6tati5MnT+LYsWPo3r07CgoKisS6fft2DB8+HG5ubnj06BG2b98u95z69u2L1NRU7N69G+fOnUPjxo3RoUMHPHv2DACwZcsWhISEYP78+YiLi4OlpSVWrlypiJfzvZR6uaFLly7o0qWL3G2CICAiIgIzZ85Ez549AQDr1q2Dubk5duzYgQEDBsjdLzc3F7m5udLnGRkZig+ciIiUpmrVqli+fDnU1dXh5OSErl27IjY2FsOHD8fdu3ehq6uLbt26QV9fH7Vq1UKjRo1k9re2tsbixYshEolQp04dXL58GYsXL5buHxUVhbt378LKygoAMGnSJOzZswdRUVGYP38+Fi5ciCZNmsh8SderV09urMbGxtDR0YGmpiYsLCzk1jl27BjOnDmD1NRUiMViAMAPP/yAHTt2YNu2bRgxYgQiIiLg5+cHPz8/AMDcuXNx4MCBMv/RXGHHJCQnJyMlJQUeHh7SMkNDQzRr1gwnT558Z5IQFhaG0NDQ8gpT4S5X76bsEIiIKrR69epBXV1d+tzS0hKXL18GAHTs2BG1atWCnZ0dOnfujM6dO6N3797Q0dGR1m/evDlEIpH0uZubGxYtWoSCggJcvnwZBQUFqF27tswxc3NzYWJiAuB1T0Lfvn0Vdj4XL15EZmamtP1CL1++RFJSEgAgISEBo0aNktnu5uaGgwcPKiwOeSpskpCSkgIAMDc3lyk3NzeXbpMnKCgIgYGB0ucZGRmwtrYumyCJiEhhDAwMkJ6eXqQ8LS0NhoaG0udvzhwAAJFIBIlEAgDQ19fH+fPncejQIezbtw+zZ89GSEgIzp49CyMjow/GkJmZCXV1dZw7d04mEQEAPT09AIC2tnZJT+2Dx7S0tCwy7gFAsWIuS5VuMSWxWAwDAwOZBxERVXx16tTB+fPni5SfP3++yC/796lSpQo8PDywcOFCXLp0Cbdv38Y///wj3X769GmZ+qdOnYKjoyPU1dXRqFEjFBQUIDU1FQ4ODjKPwssF9evXR2xsbCnPsqjGjRsjJSUFVapUKXJMU1NTAICzs7PcuMtahU0SCt+Mx48fy5Q/fvz4ndd1iIjo0/XNN9/g+vXrGDt2LC5duoTExESEh4dj48aNmDhxYrHa2LVrF5YuXYr4+HjcuXMH69atg0QiQZ06daR17t69i8DAQCQmJmLjxo1YtmwZxo0bBwCoXbs2Bg8eDG9vb2zfvh3Jyck4c+YMwsLC8NdffwF43WN99uxZ+Pv749KlS7h27RoiIyPx33//leq8PTw84Obmhl69emHfvn24ffs2Tpw4gRkzZiAuLg4AMG7cOKxduxZRUVG4fv06goODceXKlVIdryQq7OUGW1tbWFhYIDY2Fg0bNgTw+tLB6dOn8c033yg3OCKiT8ynsAKinZ0djhw5ghkzZsDDwwN5eXlwcnLC1q1b0blz52K1YWRkhO3btyMkJAQ5OTlwdHTExo0bZQYWent74+XLl2jatCnU1dUxbtw4jBgxQro9KioKc+fOxcSJE/HgwQOYmpqiefPm6Nbt9Zix2rVrY9++fZg+fTqaNm0KbW1tNGvWDAMHDizVeYtEIvz999+YMWMGhgwZgidPnsDCwgKtW7eWXnLv378/kpKSMGXKFOTk5MDLywvffPMN9u7dW6pjFjs24c3JoeUsMzMTN2/eBAA0atQI4eHhaNeuHYyNjVGzZk0sWLAA3333HWJiYmBra4tZs2bh0qVLuHr1KrS0tIp1jIyMDBgaGiI9Pf3TuPRwIEjZESiWR5iyI6Ay9Pupxx+u9Anp3dz8w5UqgPf9XcvJyUFycjJsbW2L/XdSlbxrVUdVU9zPiVJ7EuLi4tCuXTvp88IBhz4+PoiOjsaUKVOQlZWFESNGIC0tDS1btsSePXv4wSciIioHSk0S2rZti/d1ZIhEIsyZMwdz5swpx6iIiIgIqMBjEoio4puwI07ZIShU7+ZdlR0ClTF50wzp3Srs7AYiIio9JQ43o09AcT8fTBKIiCqRwoWGsrOzlRwJVWSFn4+3F6Z6Gy83EBFVIurq6jAyMkJqaioAQEdHR2YJYlJtgiAgOzsbqampMDIyKrKq5NuYJBARVTKFC84VJgpEbzMyMirWwoRMEoiIKhmRSARLS0tUq1YN+fn5yg6HKhgNDY0P9iAUYpJARFRJqaurF/vLgEgeDlwkIiIiuZgkEBERkVxMEoiIiEguJglEREQkFwcuVjTHVio7AsXiXSCJiD5Z7EkgIiIiuZgkEBERkVxMEoiIiEgujkmoYH7vfF3ZIShUb2UHQEREpcaeBCIiIpKLSQIRERHJxSSBiIiI5GKSQERERHIxSSAiIiK5mCQQERGRXEwSiIiISC6uk1DBTNgRp+wQFKp3867KDoGIiEqJPQlEREQkF5MEIiIikotJAhEREcn1SSQJK1asgI2NDbS0tNCsWTOcOXNG2SERERFVehU+Sdi8eTMCAwMRHByM8+fPo0GDBvD09ERqaqqyQyMiIqrUKvzshvDwcAwfPhxDhgwBAKxatQp//fUX1q5di2nTphWpn5ubi9zcXOnz9PR0AEBGRkb5BPyRJLnZyg5BoT6V151Kh59X5SiMUxAEJUdClZ1IqMCfsry8POjo6GDbtm3o1auXtNzHxwdpaWn4448/iuwTEhKC0NDQcoySiEg57t27hxo1aig7DKrEKnRPwn///YeCggKYm5vLlJubm+PatWty9wkKCkJgYKD0uUQiwbNnz2BiYgKRSFSm8X4qMjIyYG1tjXv37sHAwEDZ4RC9Fz+vRQmCgBcvXsDKykrZoVAlV6GThNIQi8UQi8UyZUZGRsoJpoIzMDDgH136ZPDzKsvQ0FDZIZAKqNADF01NTaGuro7Hjx/LlD9+/BgWFhZKioqIiEg1VOgkQVNTE66uroiNjZWWSSQSxMbGws3NTYmRERERVX4V/nJDYGAgfHx80KRJEzRt2hQRERHIysqSznagkhOLxQgODi5yWYaoIuLnlUh5KvTshkLLly/H999/j5SUFDRs2BBLly5Fs2bNlB0WERFRpfZJJAlERERU/ir0mAQiIiJSHiYJREREJBeTBCIiIpKLSQIRERHJxSSBiCoUOzs7PH36tEh5Wloa7OzslBARkepikkBEFcrt27dRUFBQpDw3NxcPHjxQQkREqqvCL6ZEH6+goADR0dGIjY1FamoqJBKJzPZ//vlHSZER/c/OnTul/967d6/MvQkKCgoQGxsLGxsbJURGpLq4ToIKGD16NKKjo9G1a1dYWloWuRvm4sWLlRQZ0f+oqb3u2BSJRHj7z5KGhgZsbGywaNEidOvWTRnhEakkJgkqwNTUFOvWrcMXX3yh7FCIPsjW1hZnz56FqampskMhUnm83KACNDU14eDgoOwwiIolOTm5SFlaWhpv+U6kBBy4qAImTpyIJUuWFOnCJaqIFixYgM2bN0uf9+3bF8bGxqhevTouXryoxMiIVA8vN6iA3r174+DBgzA2Nka9evWgoaEhs3379u1KioyoKFtbW6xfvx4tWrTA/v370a9fP2zevBlbtmzB3bt3sW/fPmWHSKQyeLlBBRgZGaF3797KDoOoWFJSUmBtbQ0A2LVrF/r164dOnTrBxsaGd38lKmdMElRAVFSUskMgKraqVavi3r17sLa2xp49ezB37lwAgCAIctdPIKKywyRBhTx58gSJiYkAgDp16sDMzEzJEREV1adPHwwaNAiOjo54+vQpunTpAgC4cOECB+ASlTMmCSogKysLY8aMwbp166QLKamrq8Pb2xvLli2Djo6OkiMk+p/FixfDxsYG9+7dw8KFC6GnpwcAePToEfz9/ZUcHZFq4cBFFTBy5EgcOHAAy5cvh7u7OwDg2LFjGDt2LDp27IjIyEglR0hERBURkwQVYGpqim3btqFt27Yy5QcPHkS/fv3w5MkT5QRG9A6//PILVq9ejVu3buHkyZOoVasWIiIiYGtri549eyo7PCKVwXUSVEB2djbMzc2LlFerVg3Z2dlKiIjo3SIjIxEYGIguXbogLS1NOljRyMgIERERyg2OSMUwSVABbm5uCA4ORk5OjrTs5cuXCA0NhZubmxIjIypq2bJl+OmnnzBjxgyoq6tLy5s0aYLLly8rMTIi1cOBiypgyZIl8PT0RI0aNdCgQQMAwMWLF6GlpYW9e/cqOToiWcnJyWjUqFGRcrFYjKysLCVERKS6mCSogM8++ww3btzA+vXrce3aNQDAwIEDMXjwYGhrays5OiJZtra2iI+PR61atWTK9+zZA2dnZyVFRaSamCSoCB0dHQwfPlzZYRC905w5czBp0iQEBgYiICAAOTk5EAQBZ86cwcaNGxEWFoaff/5Z2WESqRTObqikdu7ciS5dukBDQwM7d+58b90ePXqUU1RE76auro5Hjx6hWrVqWL9+PUJCQpCUlAQAsLKyQmhoKPz8/JQcJZFqYZJQSampqSElJQXVqlWDmtq7x6eKRCIudUsVwpuf2ULZ2dnIzMyUKSOi8sPLDZVU4cqKb/+bqCITiUQyz3V0dLgiKJEScQqkCli3bh1yc3OLlOfl5WHdunVKiIhIvtq1a8PY2Pi9DyIqP7zcoALevNb7pqdPn6JatWq83EAVgpqaGiIiImBoaPjeej4+PuUUERHxcoMKEAShSDcuANy/f/+Df5CJytOAAQM4/oCoAmGSUIk1atQIIpEIIpEIHTp0QJUq/3u7CwoKkJycjM6dOysxQqL/kZfIEpFyMUmoxHr16gUAiI+Ph6enp/SWuwCgqakJGxsbeHl5KSk6Ilm88klU8XBMggqIiYlB//79oaWlpexQiIjoE8IkgYiIiOTi5QYVUFBQgMWLF2PLli24e/cu8vLyZLY/e/ZMSZEREVFFxnUSVEBoaCjCw8PRv39/pKenIzAwEH369IGamhpCQkKUHR4REVVQvNygAuzt7bF06VJ07doV+vr6iI+Pl5adOnUKGzZsUHaIRERUAbEnQQWkpKTAxcUFAKCnp4f09HQAQLdu3fDXX38pMzQiIqrAmCSogBo1auDRo0cAXvcq7Nu3DwBw9uxZiMViZYZGREQVGJMEFdC7d2/ExsYCAMaMGYNZs2bB0dER3t7eGDp0qJKjIyKiiopjElTQyZMncfLkSTg6OqJ79+7KDoeIiCooJglEREQkF9dJqKR27txZ7Lo9evQow0iIiOhTxZ6ESkpNTXa4iUgkKrI2fuENdXiraCIikocDFyspiUQifezbtw8NGzbE7t27kZaWhrS0NOzevRuNGzfGnj17lB0qERFVUOxJUAGfffYZVq1ahZYtW8qUHz16FCNGjEBCQoKSIiMiooqMPQkqICkpCUZGRkXKDQ0Ncfv27XKPh4iIPg3sSVABrVu3hpaWFn755ReYm5sDAB4/fgxvb2/k5OTg8OHDSo6QiIgqIiYJKuDmzZvo3bs3rl+/DmtrawDAvXv34OjoiB07dsDBwUHJERIRUUXEJEFFCIKA/fv349q1awAAZ2dneHh4SGc4EBERvY1JAhEREcnFxZQqqaVLl2LEiBHQ0tLC0qVL31t37Nix5RQVERF9StiTUEnZ2toiLi4OJiYmsLW1fWc9kUiEW7dulWNkRET0qWCSQERERHJxnQQiIiKSi2MSKqnAwMBi1w0PDy/DSIiI6FPFJKGSunDhQrHqcQokERG9C8ckEBERkVwck0BERERy8XKDioiLi8OWLVtw9+5d5OXlyWzbvn27kqIiIqKKjD0JKmDTpk1o0aIFEhIS8PvvvyM/Px9XrlzBP//8A0NDQ2WHR0REFRSTBBUwf/58LF68GH/++Sc0NTWxZMkSXLt2Df369UPNmjWVHR4REVVQTBJUQFJSErp27QoA0NTURFZWFkQiESZMmIAff/xRydEREVFFxSRBBVStWhUvXrwAAFSvXh3//vsvACAtLQ3Z2dnKDI2IiCowJgmVWGEy0Lp1a+zfvx8A0LdvX4wbNw7Dhw/HwIED0aFDB2WGSEREFRjXSajE1NTU8Pnnn6NXr1746quvYG1tDYlEgoULF+LEiRNwdHTEzJkzUbVqVWWHSkREFRCThErs6NGjiIqKwrZt2yCRSODl5YVhw4ahVatWyg6NiIg+AUwSVEBWVha2bNmC6OhoHD16FA4ODvDz84OPjw8sLCyUHR4REVVQTBJUzM2bNxEVFYVffvkFKSkp6Ny5M3bu3KnssIiIqAJikqCCsrKysH79egQFBSEtLQ0FBQXKDomIiCogLsusQo4cOYK1a9fit99+g5qaGvr16wc/Pz9lh0VERBUUexIquYcPHyI6OhrR0dG4efMmWrRoAT8/P/Tr1w+6urrKDo+IiCow9iRUYl26dMGBAwdgamoKb29vDB06FHXq1FF2WERE9IlgklCJaWhoYNu2bejWrRvU1dWVHQ4REX1ieLmBiIiI5OKyzERERCQXkwQiIiKSi0kCERERycUkgYiIiORikkBERERyMUkgIiIiuZgkEBERkVz/B3Loa7t0fLq5AAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 400x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "categories=real_world_db_entity_mapped['cancer_category'].unique()\n",
    "palette = sns.color_palette(\"tab20\", n_colors=len(categories))  # qualitative, up to 20 colors\n",
    "\n",
    "counts = pd.DataFrame({\n",
    "    'Validation': val['cancer_category'].value_counts(),\n",
    "    'Test': test['cancer_category'].value_counts()\n",
    "}).fillna(0)\n",
    "\n",
    "counts.T.plot(kind='bar', stacked=True, color=palette, figsize=(4,4), width=0.3)\n",
    "plt.ylabel(\"Number of queries\")\n",
    "plt.title(\"Cancer type distribution across splits\")\n",
    "plt.legend(loc='center left', bbox_to_anchor=(1, 0.5))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 179,
   "id": "934ccf2a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "prompt",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cancer_category",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cancer_type",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "biomarker",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "dataset",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "0eb022b4-2177-49bd-b165-6abf07a20911",
       "rows": [
        [
         "0",
         "what is the first-line treatment of metastatic urothelial carcinoma with fgfr3 s249c mutation?",
         "GU",
         "['urothelial carcinoma', 'metastatic']",
         "['fgfr3']",
         "test"
        ],
        [
         "1",
         "are parp inhibitors used for patients with leiomyosarcoma who have mutations in dna damage repair genes?",
         "Sarcoma",
         "['leiomyosarcoma']",
         "['dna', 'parp']",
         "test"
        ],
        [
         "2",
         "are alk inhibitors approved for use in tfcp2 fusion positive rhabdomyosarcoma?",
         "Sarcoma",
         "['rhabdomyosarcoma']",
         "['alk', 'tfcp2']",
         "validation"
        ],
        [
         "3",
         "for a patient with cancer metastatic prostate cancer, advanced stage (most often stage iv, but some stage iii or earlier potentially) and with brca2 mutation, what drugs approved?",
         "GU",
         "['prostate cancer', 'cancer']",
         "['brca2']",
         "test"
        ],
        [
         "4",
         "for a patient with her2+ breast cancer after neoadjvuant chemotherapy + trastuzumab then surgery, if residual disease at time of surgery, what treatment options are approved afterwards?",
         "Breast",
         "['breast cancer', 'disease']",
         "['her2']",
         "test"
        ]
       ],
       "shape": {
        "columns": 5,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>prompt</th>\n",
       "      <th>cancer_category</th>\n",
       "      <th>cancer_type</th>\n",
       "      <th>biomarker</th>\n",
       "      <th>dataset</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>what is the first-line treatment of metastatic...</td>\n",
       "      <td>GU</td>\n",
       "      <td>['urothelial carcinoma', 'metastatic']</td>\n",
       "      <td>['fgfr3']</td>\n",
       "      <td>test</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>are parp inhibitors used for patients with lei...</td>\n",
       "      <td>Sarcoma</td>\n",
       "      <td>['leiomyosarcoma']</td>\n",
       "      <td>['dna', 'parp']</td>\n",
       "      <td>test</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>are alk inhibitors approved for use in tfcp2 f...</td>\n",
       "      <td>Sarcoma</td>\n",
       "      <td>['rhabdomyosarcoma']</td>\n",
       "      <td>['alk', 'tfcp2']</td>\n",
       "      <td>validation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>for a patient with cancer metastatic prostate ...</td>\n",
       "      <td>GU</td>\n",
       "      <td>['prostate cancer', 'cancer']</td>\n",
       "      <td>['brca2']</td>\n",
       "      <td>test</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>for a patient with her2+ breast cancer after n...</td>\n",
       "      <td>Breast</td>\n",
       "      <td>['breast cancer', 'disease']</td>\n",
       "      <td>['her2']</td>\n",
       "      <td>test</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              prompt cancer_category  \\\n",
       "0  what is the first-line treatment of metastatic...              GU   \n",
       "1  are parp inhibitors used for patients with lei...         Sarcoma   \n",
       "2  are alk inhibitors approved for use in tfcp2 f...         Sarcoma   \n",
       "3  for a patient with cancer metastatic prostate ...              GU   \n",
       "4  for a patient with her2+ breast cancer after n...          Breast   \n",
       "\n",
       "                              cancer_type         biomarker     dataset  \n",
       "0  ['urothelial carcinoma', 'metastatic']         ['fgfr3']        test  \n",
       "1                      ['leiomyosarcoma']   ['dna', 'parp']        test  \n",
       "2                    ['rhabdomyosarcoma']  ['alk', 'tfcp2']  validation  \n",
       "3           ['prostate cancer', 'cancer']         ['brca2']        test  \n",
       "4            ['breast cancer', 'disease']          ['her2']        test  "
      ]
     },
     "execution_count": 179,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "real_world_db_entity_mapped.to_csv(f\"data/real_world_db/real_world_db_split__{_VERSION}.csv\")\n",
    "real_world_db_entity_mapped.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 178,
   "id": "49b6da04",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(f\"data/real_world_db/real_world_validation_query__{_VERSION}.json\", \"w\") as f:\n",
    "    json.dump(val['prompt'].tolist(), f)\n",
    "\n",
    "with open(f\"data/real_world_db/real_world_test_query__{_VERSION}.json\", \"w\") as f:\n",
    "    json.dump(test['prompt'].tolist(), f)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "25270602",
   "metadata": {},
   "source": [
    "Create ground-truth answers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 187,
   "id": "c1caf381",
   "metadata": {},
   "outputs": [],
   "source": [
    "real_world_db=pd.read_csv(f\"data/real_world_db/updated_real_world_queries_answers__{_VERSION}.csv\", index_col=0)\n",
    "real_world_db=real_world_db.dropna(subset='Questions').reset_index(drop=True)\n",
    "real_world_db_entity_mapped['All_onlabel_groundtruth_therapies_cleaned__v2'] = None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 188,
   "id": "f2c339e6",
   "metadata": {},
   "outputs": [],
   "source": [
    "def parse_therapies(entry):\n",
    "    if isinstance(entry, str):\n",
    "        parts = entry.split(',')\n",
    "        if len(parts) > 1:\n",
    "            return [set(d.strip().split(' + ')) for d in parts]\n",
    "        else:\n",
    "            return [set(parts)]\n",
    "    else:\n",
    "        return []\n",
    "    \n",
    "real_world_db_entity_mapped['All_onlabel_groundtruth_therapies_cleaned__v2']=real_world_db['All_onlabel_groundtruth_therapies_cleaned__v1'].apply(parse_therapies)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 189,
   "id": "4f8d804d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "prompt",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cancer_category",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cancer_type",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "biomarker",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "dataset",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "All_onlabel_groundtruth_therapies_cleaned__v2",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "ref": "523c3cbe-d9f9-47c4-95ed-853a101c6069",
       "rows": [
        [
         "0",
         "what is the first-line treatment of metastatic urothelial carcinoma with fgfr3 s249c mutation?",
         "GU",
         "['urothelial carcinoma', 'metastatic']",
         "['fgfr3']",
         "test",
         "[{'erdafitinib'}]"
        ],
        [
         "1",
         "are parp inhibitors used for patients with leiomyosarcoma who have mutations in dna damage repair genes?",
         "Sarcoma",
         "['leiomyosarcoma']",
         "['dna', 'parp']",
         "test",
         "[]"
        ],
        [
         "2",
         "are alk inhibitors approved for use in tfcp2 fusion positive rhabdomyosarcoma?",
         "Sarcoma",
         "['rhabdomyosarcoma']",
         "['alk', 'tfcp2']",
         "validation",
         "[]"
        ],
        [
         "3",
         "for a patient with cancer metastatic prostate cancer, advanced stage (most often stage iv, but some stage iii or earlier potentially) and with brca2 mutation, what drugs approved?",
         "GU",
         "['prostate cancer', 'cancer']",
         "['brca2']",
         "test",
         "[{'abiraterone acetate', 'niraparib', 'prednisolone'}, {'abiraterone acetate', 'prednisolone', 'olaparib'}, {'enzalutamide', 'talazoparib'}, {'olaparib'}, {'rucaparib'}]"
        ],
        [
         "4",
         "for a patient with her2+ breast cancer after neoadjvuant chemotherapy + trastuzumab then surgery, if residual disease at time of surgery, what treatment options are approved afterwards?",
         "Breast",
         "['breast cancer', 'disease']",
         "['her2']",
         "test",
         "[{'trastuzumab emtansine'}]"
        ]
       ],
       "shape": {
        "columns": 6,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>prompt</th>\n",
       "      <th>cancer_category</th>\n",
       "      <th>cancer_type</th>\n",
       "      <th>biomarker</th>\n",
       "      <th>dataset</th>\n",
       "      <th>All_onlabel_groundtruth_therapies_cleaned__v2</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>what is the first-line treatment of metastatic...</td>\n",
       "      <td>GU</td>\n",
       "      <td>['urothelial carcinoma', 'metastatic']</td>\n",
       "      <td>['fgfr3']</td>\n",
       "      <td>test</td>\n",
       "      <td>[{erdafitinib}]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>are parp inhibitors used for patients with lei...</td>\n",
       "      <td>Sarcoma</td>\n",
       "      <td>['leiomyosarcoma']</td>\n",
       "      <td>['dna', 'parp']</td>\n",
       "      <td>test</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>are alk inhibitors approved for use in tfcp2 f...</td>\n",
       "      <td>Sarcoma</td>\n",
       "      <td>['rhabdomyosarcoma']</td>\n",
       "      <td>['alk', 'tfcp2']</td>\n",
       "      <td>validation</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>for a patient with cancer metastatic prostate ...</td>\n",
       "      <td>GU</td>\n",
       "      <td>['prostate cancer', 'cancer']</td>\n",
       "      <td>['brca2']</td>\n",
       "      <td>test</td>\n",
       "      <td>[{abiraterone acetate, niraparib, prednisolone...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>for a patient with her2+ breast cancer after n...</td>\n",
       "      <td>Breast</td>\n",
       "      <td>['breast cancer', 'disease']</td>\n",
       "      <td>['her2']</td>\n",
       "      <td>test</td>\n",
       "      <td>[{trastuzumab emtansine}]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              prompt cancer_category  \\\n",
       "0  what is the first-line treatment of metastatic...              GU   \n",
       "1  are parp inhibitors used for patients with lei...         Sarcoma   \n",
       "2  are alk inhibitors approved for use in tfcp2 f...         Sarcoma   \n",
       "3  for a patient with cancer metastatic prostate ...              GU   \n",
       "4  for a patient with her2+ breast cancer after n...          Breast   \n",
       "\n",
       "                              cancer_type         biomarker     dataset  \\\n",
       "0  ['urothelial carcinoma', 'metastatic']         ['fgfr3']        test   \n",
       "1                      ['leiomyosarcoma']   ['dna', 'parp']        test   \n",
       "2                    ['rhabdomyosarcoma']  ['alk', 'tfcp2']  validation   \n",
       "3           ['prostate cancer', 'cancer']         ['brca2']        test   \n",
       "4            ['breast cancer', 'disease']          ['her2']        test   \n",
       "\n",
       "       All_onlabel_groundtruth_therapies_cleaned__v2  \n",
       "0                                    [{erdafitinib}]  \n",
       "1                                                 []  \n",
       "2                                                 []  \n",
       "3  [{abiraterone acetate, niraparib, prednisolone...  \n",
       "4                          [{trastuzumab emtansine}]  "
      ]
     },
     "execution_count": 189,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "real_world_db_entity_mapped.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "24b511f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "real_world_db_entity_mapped.to_csv(f\"data/real_world_db/real_world_db__{_VERSION}.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 198,
   "id": "837733d4",
   "metadata": {},
   "outputs": [],
   "source": [
    "real_world_query_therapy_pair_dict= dict(zip(real_world_db_entity_mapped['prompt'], real_world_db_entity_mapped['All_onlabel_groundtruth_therapies_cleaned__v2']))\n",
    "\n",
    "save_object(real_world_query_therapy_pair_dict, f\"data/real_world_db/real_world_query_therapy_pair_dict.pkl\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.14"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
